results

+#Cluster:  1
+3_s   3
+17_s   17
+33_s   33
+42_s   42
+43_s   43
+59_s   59
+66_s   66
+82_s   82
+84_s   84
+100_s   100
+123_s   123
+124_s   124
+132_s   131
+136_s   135
+137_s   136
+148_s   147
+188_s   186
+196_s   194
+216_s   214
+219_s   217
+226_s   224
+227_s   225
+229_s   227
+230_s   228
+234_s   232
+238_s   236
+244_s   242
+245_s   243
+269_s   266
+275_s   272
+281_s   278
+287_s   284
+290_s   287
+301_s   297
+302_s   298
+303_s   299
+315_s   311
+332_s   328
+350_s   346
+361_s   357
+366_s   362
+379_s   375
+415_s   411
+421_s   417
+444_s   440
+445_s   441
+446_s   442
+453_s   449
+#Cluster:  2
+6_s   6
+18_s   18
+24_s   24
+25_s   25
+29_s   29
+37_s   37
+38_s   38
+44_s   44
+47_s   47
+55_s   55
+65_s   65
+69_s   69
+70_s   70
+71_s   71
+72_s   72
+79_s   79
+81_s   81
+86_s   86
+92_s   92
+94_s   94
+101_s   101
+102_s   102
+104_s   104
+110_s   110
+112_s   112
+115_s   115
+118_s   118
+120_s   120
+127_s   126
+128_s   127
+130_s   129
+144_s   143
+146_s   145
+156_s   155
+161_s   160
+164_s   163
+166_s   165
+169_s   168
+179_s   177
+182_s   180
+186_s   184
+189_s   187
+192_s   190
+195_s   193
+204_s   202
+205_s   203
+208_s   206
+217_s   215
+221_s   219
+222_s   220
+223_s   221
+225_s   223
+233_s   231
+236_s   234
+241_s   239
+242_s   240
+247_s   245
+260_s   257
+262_s   259
+265_s   262
+272_s   269
+278_s   275
+279_s   276
+280_s   277
+284_s   281
+289_s   286
+297_s   293
+300_s   296
+307_s   303
+308_s   304
+310_s   306
+316_s   312
+318_s   314
+320_s   316
+326_s   322
+330_s   326
+335_s   331
+336_s   332
+340_s   336
+348_s   344
+352_s   348
+353_s   349
+355_s   351
+357_s   353
+371_s   367
+383_s   379
+384_s   380
+392_s   388
+399_s   395
+402_s   398
+408_s   404
+411_s   407
+413_s   409
+414_s   410
+418_s   414
+419_s   415
+424_s   420
+428_s   424
+429_s   425
+433_s   429
+438_s   434
+440_s   436
+447_s   443
+450_s   446
+#Cluster:  3
+1_s   1
+5_s   5
+7_s   7
+8_s   8
+10_s   10
+12_s   12
+13_s   13
+14_s   14
+16_s   16
+20_s   20
+22_s   22
+23_s   23
+28_s   28
+31_s   31
+34_s   34
+48_s   48
+49_s   49
+54_s   54
+58_s   58
+64_s   64
+67_s   67
+74_s   74
+75_s   75
+80_s   80
+83_s   83
+87_s   87
+88_s   88
+89_s   89
+90_s   90
+91_s   91
+93_s   93
+98_s   98
+106_s   106
+109_s   109
+117_s   117
+138_s   137
+141_s   140
+142_s   141
+147_s   146
+149_s   148
+150_s   149
+159_s   158
+162_s   161
+163_s   162
+165_s   164
+171_s   169
+174_s   172
+177_s   175
+184_s   182
+190_s   188
+197_s   195
+198_s   196
+199_s   197
+203_s   201
+210_s   208
+214_s   212
+215_s   213
+220_s   218
+237_s   235
+239_s   237
+240_s   238
+243_s   241
+246_s   244
+248_s   246
+250_s   248
+251_s   249
+253_s   250
+254_s   251
+255_s   252
+256_s   253
+264_s   261
+268_s   265
+273_s   270
+286_s   283
+291_s   288
+293_s   289
+295_s   291
+298_s   294
+299_s   295
+305_s   301
+313_s   309
+314_s   310
+317_s   313
+322_s   318
+325_s   321
+328_s   324
+333_s   329
+343_s   339
+345_s   341
+347_s   343
+349_s   345
+354_s   350
+356_s   352
+360_s   356
+362_s   358
+363_s   359
+364_s   360
+365_s   361
+367_s   363
+368_s   364
+372_s   368
+374_s   370
+375_s   371
+376_s   372
+377_s   373
+378_s   374
+380_s   376
+387_s   383
+388_s   384
+390_s   386
+391_s   387
+398_s   394
+401_s   397
+403_s   399
+407_s   403
+409_s   405
+416_s   412
+420_s   416
+431_s   427
+437_s   433
+442_s   438
+443_s   439
+448_s   444
+451_s   447
+452_s   448
+#Cluster:  4 
+9_s   9
+19_s   19
+21_s   21
+26_s   26
+32_s   32
+39_s   39
+52_s   52
+73_s   73
+77_s   77
+95_s   95
+107_s   107
+113_s   113
+125_s   125
+129_s   128
+131_s   130
+145_s   144
+153_s   152
+158_s   157
+172_s   170
+175_s   173
+180_s   178
+200_s   198
+202_s   200
+207_s   205
+224_s   222
+228_s   226
+231_s   229
+259_s   256
+263_s   260
+274_s   271
+283_s   280
+288_s   285
+306_s   302
+321_s   317
+323_s   319
+334_s   330
+359_s   355
+382_s   378
+395_s   391
+417_s   413
+434_s   430
+454_s   450
+#Cluster:  5
+2_s   2
+4_s   4
+11_s   11
+15_s   15
+27_s   27
+30_s   30
+35_s   35
+36_s   36
+40_s   40
+41_s   41
+45_s   45
+46_s   46
+50_s   50
+51_s   51
+53_s   53
+56_s   56
+57_s   57
+60_s   60
+61_s   61
+62_s   62
+63_s   63
+68_s   68
+76_s   76
+78_s   78
+85_s   85
+96_s   96
+97_s   97
+99_s   99
+103_s   103
+105_s   105
+108_s   108
+111_s   111
+114_s   114
+116_s   116
+119_s   119
+121_s   121
+122_s   122
+133_s   132
+134_s   133
+135_s   134
+139_s   138
+140_s   139
+143_s   142
+151_s   150
+152_s   151
+154_s   153
+155_s   154
+157_s   156
+160_s   159
+167_s   166
+168_s   167
+173_s   171
+176_s   174
+178_s   176
+181_s   179
+183_s   181
+185_s   183
+187_s   185
+191_s   189
+193_s   191
+194_s   192
+201_s   199
+206_s   204
+209_s   207
+211_s   209
+212_s   210
+213_s   211
+218_s   216
+232_s   230
+235_s   233
+249_s   247
+257_s   254
+258_s   255
+261_s   258
+266_s   263
+267_s   264
+270_s   267
+271_s   268
+276_s   273
+277_s   274
+282_s   279
+285_s   282
+294_s   290
+296_s   292
+304_s   300
+309_s   305
+311_s   307
+312_s   308
+319_s   315
+324_s   320
+327_s   323
+329_s   325
+331_s   327
+337_s   333
+338_s   334
+339_s   335
+341_s   337
+342_s   338
+344_s   340
+346_s   342
+351_s   347
+358_s   354
+369_s   365
+370_s   366
+373_s   369
+381_s   377
+385_s   381
+386_s   382
+389_s   385
+393_s   389
+394_s   390
+396_s   392
+397_s   393
+400_s   396
+404_s   400
+405_s   401
+406_s   402
+410_s   406
+412_s   408
+422_s   418
+423_s   419
+425_s   421
+426_s   422
+427_s   423
+430_s   426
+432_s   428
+435_s   431
+436_s   432
+439_s   435
+441_s   437
+449_s   445
+455_s   451

+Tissue inhibitor of metalloproteinase-3 is up-regulated by transforming growth factor-beta1 in vitro and expressed in fibroblastic foci in vivo in idiopathic pulmonary fibrosis
+Upregulation of alveolar levels of activin B, but not activin A, in lungs of west highland white terriers with idiopathic pulmonary fibrosis and diffuse alveolar damage
+Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor
+Upregulation of activin-B and follistatin in pulmonary fibrosis - a translational study using human biopsies and a specific inhibitor in mouse fibrosis models
+Resveratrol inhibits transforming growth factor-b-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration
+Interactions between b-catenin and transforming growth factor-b signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP)
+Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-b receptor I internalization and inhibiting transforming growth factor-b1 signaling
+Lower expression of platelet derived growth factor is associated with better overall survival rate of patients with idiopathic nonspecific interstitial pneumonia
+TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study
+Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis
+Significance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis patients
+The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo
+Human placental mesenchymal stem cells of fetal origins-alleviated inflammation and fibrosis by attenuating MyD88 signaling in bleomycin-induced pulmonary fibrosis mice
+Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression
+Phosphatase and tensin homolog deleted on chromosome 10 contributes to phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis via multiple pathways
+Transforming growth factor-b1 downregulates vascular endothelial growth factor-D expression in human lung fibroblasts via the Jun NH2-terminal kinase signaling pathway
+The anti-fibrotic effect of inhibition of TGFb-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent y-herpesvirus infection
+Transforming growth factor-b inhibits IQ motif containing guanosine triphosphatase activating protein  1 expression in lung fibroblasts via the nuclear factor-kB signaling pathway
+De-ubiquitinating enzyme, USP11, promotes transforming growth factor b-1 signaling through stabilization of transforming growth factor b receptor II
+Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor b receptor-dependent and -independent pathways
+Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition
+Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways
+Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis
+Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism
+Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation
+NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts
+Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-b1 and plasminogen activator inhibitor 1
+Comparative study of transforming growth factor-b signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis
+Microsatellite instability in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of idiopathic pulmonary fibrosis
+Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta
+Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition
+Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-b1 in A549, NCI-H441, and Calu-3 cells: Development of an in vitro model of respiratory epithelial cells in idiopathic pulmonary fibrosis
+TGF-b1 stimulates HDAC4 nucleus-to-cytoplasm translocation and NADPH oxidase 4-derived reactive oxygen species in normal human lung fibroblasts
+Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-b
+Differential mRNA expression of insulin-like growth factor-1 splice variants in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis
+The hedgehog system machinery controls transforming growth factor-b-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis
+Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis
+Are mast cells instrumental for fibrotic diseases? Idiopathic pulmonary fibrosis (IPF) is a fatal lung disorder of unknown etiology characterized by accumulation of lung fibroblasts and extracellular matrix deposition, ultimately leading to compromised tissue architecture and lung function capacity
+The role of halofuginone in fibrosis: more to be explored? Fibrosis, which can be defined as an abnormal or excessive accumulation of extracellular matrix (ECM), particularly fibrillar collagens, is a key driver of progressive organ dysfunction in many inflammatory and metabolic diseases, including idiopathic pulmonary fibrosis (IPF), cirrhosis, nephropathy, and oral submucous fibrosis (OSF)
+CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis
+Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis? Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal lung disease with no known etiology and treatment options
+The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--b1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells
+PI3K p110y overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition
+Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase
+Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK
+Secreted protein acidic and rich in cysteine (SPARC) is upregulated by transforming growth factor (TGF)-b and is required for TGF-b-induced hydrogen peroxide production in fibroblasts
+Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-b1-induced pulmonary fibrosis
+Arsenic trioxide inhibits transforming growth factor-b1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo

+Resveratrol inhibits transforming growth factor-b-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through <g>ERK</g>/<g>Akt</g> <u>inhibition </u>and <g>PTEN</g> restoration
+Signaling pathways in the epithelial origins of <d>pulmonary fibrosis</d>
+Raised serum levels of <g>IGFBP-1</g> and <g>IGFBP-2</g> in <d>idiopathic pulmonary fibrosis</d>
+Methylation-mediated <g>BMPER</g> <e>expression </e>in fibroblast activation in vitro and lung <d>fibrosis</d> in mice in vivo
+<d>Fibrosis</d> of two: Epithelial cell-fibroblast interactions in <d>pulmonary fibrosis</d>
+Arsenic trioxide inhibits transforming growth factor-b1-induced <d>fibroblast to myofibroblast differentiation</d> in vitro and bleomycin induced lung <d>fibrosis</d> in vivo
+microRNA-1343 attenuates pathways of <d>fibrosis</d> by targeting the <g>TGF-b</g> receptors
+<g>Matrix metalloproteinase (MMP)-19</g> <u>deficient </u>fibroblasts display a profibrotic phenotype
+Comparative study of transforming growth factor-b signalling and regulatory molecules in human and canine <d>idiopathic pulmonary fibrosis</d>
+Genetic polymorphism in <g>matrix metalloproteinase-9</g> and <g>transforming growth factor-b1</g> and susceptibility to <d>combined pulmonary fibrosis</d> and <d>emphysema</d> in  a Chinese population
+Transforming growth factor-b1 downregulates <g>vascular endothelial growth factor</g>-D expression in human lung fibroblasts via the <g>Jun NH2-terminal kinase</g> signaling pathway
+<g>Ubiquitin carboxyl-terminal hydrolase-L5</g> promotes <g>TGFb-1</g> signaling by de-ubiquitinating and stabilizing <g>Smad2</g>/<g>Smad3</g> in <d>pulmonary fibrosis</d>
+Effect of pirfenidone on proliferation, <g>TGF-b</g>-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
+[Quantifying plasma levels of <g>transforming growth factor beta1</g> in <d>idiopathic pulmonary fibrosis</d>]
+The matricellular protein <g>CCN1</g> enhances <g>TGF-b1</g>/<g>SMAD3</g>-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to <d>lung injury</d>
+Bleomycin in the setting of <d>lung fibrosis</d> induction: From biological mechanisms to counteractions
+Alveolar epithelial cell injury with Epstein-Barr virus <v>upregulates </v><g>TGFbeta1</g> <e>expression.</e> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a refractory and lethal <d>interstitial lung disease</d> characterized by alveolar epithelial cells apoptosis, fibroblast proliferation, and ECM protein deposition
+Single-cell RNA sequencing identifies diverse roles of epithelial cells in <d>idiopathic pulmonary fibrosis</d>
+Data on <g>CUX1</g> isoforms in <d>idiopathic pulmonary fibrosis lung</d> and <d>systemic sclerosis</d> skin tissue sections
+<d>Idiopathic Pulmonary Fibrosis</d>: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
+Genetic partitioning of <g>interleukin-6</g> signalling in mice dissociates <g>Stat3</g> from <g>Smad3</g>-mediated <d>lung fibrosis</d>
+Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in <d>idiopathic pulmonary fibrosis</d>
+Oxidant-antioxidant imbalance as a potential contributor to the progression of human <d>pulmonary fibrosis</d>
+Increased production and immunohistochemical localization of <g>transforming growth factor-beta</g> in <d>idiopathic pulmonary fibrosis</d>
+Type V collagen induced tolerance suppresses collagen deposition, <g>TGF-b</g> and associated transcripts in <d>pulmonary fibrosis</d>
+Preventive and therapeutic effects of thymosin b4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis
+FAK-related nonkinase is a multifunctional negative regulator of <d>pulmonary fibrosis</d>
+Nitrated fatty acids reverse <d>pulmonary fibrosis</d> by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages
+Cytokine profiles in <d>idiopathic pulmonary fibrosis</d> suggest an important role for <g>TGF-beta</g> and <g>IL-10</g>
+Sphingosine-1-phosphate is increased in patients with <d>idiopathic pulmonary fibrosis</d> and mediates epithelial to mesenchymal transition
+Leucine-rich a-2 glycoprotein promotes <d>lung fibrosis</d> by modulating <g>TGF-b</g> signaling in fibroblasts
+Sustained <g>PI3K</g>
+Pirfenidone <u>inhibits </u>the <e>expression </e>of <g>HSP47</g> in <g>TGF-beta1</g>-stimulated human lung fibroblasts
+Age-driven developmental drift in the pathogenesis of <d>idiopathic pulmonary fibrosis</d>
+Endogenous <g>Semaphorin-7A</g>
+Progressive transforming growth factor beta1-induced <d>lung fibrosis</d> is blocked by an orally active <g>ALK5</g> kinase <u>inhibitor.</u> <d>Pulmonary fibrosis</d> is characterized by chronic scar formation and deposition of extracellular matrix, resulting in <d>impaired lung function</d> and <d>respiratory failure</d>
+Compromised peroxisomes in <d>idiopathic pulmonary fibrosis</d>, a vicious cycle inducing a higher fibrotic response via <g>TGF-b</g> signaling
+Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced <d>pulmonary fibrosis</d>
+Intrinsic defence capacity and therapeutic potential of natriuretic peptides in <d>pulmonary hypertension</d> associated with <d>lung fibrosis</d>
+Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for <d>idiopathic pulmonary fibrosis</d>
+BAL cytokine profile in different <d>interstitial lung diseases</d>: a focus on <d>systemic sclerosis</d>
+Matrix metalloproteinase 3 is a mediator of <d>pulmonary fibrosis</d>
+<u>Inhibition </u>of <g>PHGDH</g>
+Bleomycin induces molecular changes directly relevant to <d>idiopathic pulmonary fibrosis</d>: a model for "active" disease
+Lysyl oxidases <r>regulate </r>fibrillar collagen remodelling in idiopathic pulmonary fibrosis
+Discovery and validation of extracellular/circulating microRNAs during <d>idiopathic pulmonary fibrosis disease</d> progression
+Recombinant human <g>serum amyloid P</g> in healthy volunteers and patients with <d>pulmonary fibrosis</d>
+<g>Transforming Growth Factor Beta 1</g>

+EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis
+Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease
+Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis
+Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice
+Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-b1 mediated Smad2/3 and ERK1/2 activation
+Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-b1-dependent mechanism
+Methylation-mediated BMPER expression in fibroblast activation in vitro and lung fibrosis in mice in vivo
+Effects of doxycycline on production of growth factors and matrix metalloproteinases in pulmonary fibrosis
+MS80, a novel sulfated oligosaccharide, inhibits pulmonary fibrosis by targeting TGF-beta1 both in vitro and in vivo
+Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis
+Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases
+Simvastatin attenuates TGF-b1-induced epithelial-mesenchymal transition in human alveolar epithelial cells
+Expression of 150-kDa oxygen-regulated protein (ORP150) stimulates bleomycin-induced pulmonary fibrosis and dysfunction in mice
+Kinase inhibitors fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue
+The small heat-shock protein aB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis
+CUX1/Wnt signaling regulates epithelial mesenchymal transition in EBV infected epithelial cells
+Idiopathic pulmonary fibrosis: an altered fibroblast proliferation linked to cancer biology
+Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function
+TGF-b1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner
+Focal adhesion kinase signaling determines the fate of lung epithelial cells in response to TGF-b
+The profibrotic cytokine transforming growth factor-b1 increases endothelial progenitor cell angiogenic properties
+Tannic acid attenuates TGF-b1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-b signaling in lung epithelial cells
+Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta
+Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis
+Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis
+Effects of thymosin b4 and its N-terminal fragment Ac-SDKP on TGF-b-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis
+The matricellular protein CCN1 enhances TGF-b1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury
+MicroRNA-326 regulates profibrotic functions of transforming growth factor-b in pulmonary fibrosis
+Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo
+An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices
+Differential effects of human neutrophil peptide-1 on growth factor and interleukin-8 production by human lung fibroblasts and epithelial cells
+Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice
+VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats
+Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression
+miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1
+Cysteine-rich protein 1 is regulated by transforming growth factor-b1 and expressed in lung fibrosis
+Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-b-induced senescence of human bronchial epithelial cells
+Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro
+Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis
+Epithelium-specific deletion of TGF-b receptor type II protects mice from bleomycin-induced pulmonary fibrosis
+Assessment of the effect of potential antifibrotic compounds on total and aVb6 integrin-mediated TGF-b activation
+Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis
+Genetic polymorphism in matrix metalloproteinase-9 and transforming growth factor-b1 and susceptibility to combined pulmonary fibrosis and emphysema in  a Chinese population
+Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-kB dependant TGF-b activation: a biphasic experimental study
+Effect of pirfenidone on proliferation, TGF-b-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
+Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis
+[Quantifying plasma levels of transforming growth factor beta1 in idiopathic pulmonary fibrosis]
+SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin
+TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)
+NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
+TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells
+MicroRNA-29c regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts
+Regulation of human lung fibroblast C1q-receptors by transforming growth factor-beta and tumor necrosis factor-alpha
+Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
+Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis
+Increased TGF-beta1 in the lungs of asbestos-exposed rats and mice: reduced expression in TNF-alpha receptor knockout mice
+Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms
+Pirfenidone inhibits TGF-b1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells
+BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis
+Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis
+Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis
+Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy
+Roles of p38 MAPK and JNK in TGF-b1-induced human alveolar epithelial to mesenchymal transition
+The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis
+Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells
+Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts
+Triptolide suppresses paraquat induced idiopathic pulmonary fibrosis by inhibiting TGFB1-dependent epithelial mesenchymal transition
+[The morphology and molecular bases of damage to the stem cell niche of respiratory acini in idiopathic interstitial pneumonias]
+PPAR-y ligands repress TGFb-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis
+WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts
+Melatonin attenuates TGFb1-induced epithelial-mesenchymal transition in lung alveolar epithelial cells
+MiR-5100 targets TOB2 to drive epithelial-mesenchymal transition associated with activating smad2/3 in lung epithelial cells
+Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-b-induced alveolar epithelial to mesenchymal transition
+Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts
+Absence of Thy-1 results in TGF-b induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts
+Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells
+Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis
+TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: tnf-alpha induces TGF-beta(1)
+Anchorage-independent colony growth of pulmonary fibroblasts derived from fibrotic human lung tissue
+Antifibrotic effects of cyclosporine A on TGF-b1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1a
+Forkhead Box F1 (FOXF1) represses cell growth, COL1 and ARPC2 expression in lung fibroblasts in vitro
+Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages
+Modulation of specific beta cell gene (re)expression during in vitro expansion of human pancreatic islet cells
+Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis
+Amplified canonical transforming growth factor-b signalling<i>via</i>heat shock protein 90 in pulmonary fibrosis
+Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis
+Activated human T lymphocytes inhibit TGFb-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2
+Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis
+Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy
+Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts
+N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro
+Transforming growth factor beta1 induces epithelial-to-mesenchymal transition of A549 cells
+X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis
+Idiopathic pulmonary fibrosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers
+Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases
+Effects of cigarette smoke extract on A549 cells and human lung fibroblasts treated with transforming growth factor-beta1 in a coculture system
+Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis
+Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-kB, Muc5ac, TNF-a and IL-1b
+Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts
+Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF
+RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis
+Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice
+Regulation of transforming growth factor-b1-driven lung fibrosis by galectin-3
+Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury

+[Pulmonary fibrosis--a therapeutic dilemma?]
+Overexpression of <d>squamous cell carcinoma</d> antigen in <d>idiopathic pulmonary fibrosis</d>: clinicopathological correlations
+Establishment of the mouse model of acute exacerbation of <d>idiopathic pulmonary fibrosis</d>
+Dehydroepiandrosterone has strong antifibrotic effects and is decreased in <d>idiopathic pulmonary fibrosis</d>
+<g>Plasminogen activator inhibitor 1</g>, fibroblast apoptosis resistance, and aging-related susceptibility to lung <d>fibrosis</d>
+Tumor <d>necrosis</d> factor superfamily 14 (<d>LIGHT</d>) controls <g>thymic stromal lymphopoietin</g> to drive <d>pulmonary fibrosis</d>
+<g>Pigment epithelium-derived factor</g> in <d>idiopathic pulmonary fibrosis</d>: a role in aberrant angiogenesis
+Peptide-mediated inhibition of <g>mitogen-activated protein kinase-activated protein kinase-2</g> ameliorates bleomycin-induced <d>pulmonary fibrosis</d>
+Role of integrin-<v>mediated </v><g>TGFbeta</g> <v>activation </v>in the pathogenesis of <d>pulmonary fibrosis</d>
+<g>Glucagon like peptide-1</g> attenuates bleomycin-induced <d>pulmonary fibrosis</d>, involving the <u>inactivation </u>of NF-kB in mice
+<g>miR-26a</g> suppresses EMT by disrupting the <g>Lin28B</g>/<g>let-7d</g> axis: potential cross-talks among miRNAs in <d>IPF</d>
+<g>Transgelin</g> is a direct target of <g>TGF-beta</g>/<g>Smad3</g>-dependent epithelial cell <d>migration in lung fibrosis</d>
+The mannose-6-phosphate analogue, PXS64, inhibits <d>fibrosis</d> via <g>TGF-b1</g> pathway in human lung fibroblasts
+<u>Reduced </u><e>expression </e>of <g>BMP3</g> contributes to the development of <d>pulmonary fibrosis</d> and predicts the unfavorable prognosis in IIP patients
+Role of <g>CD248</g> as a potential severity marker in <d>idiopathic pulmonary fibrosis</d>
+<g>BAX inhibitor-1</g>-associated <g>V-ATPase</g> glycosylation <v>enhances </v>collagen degradation in <d>pulmonary fibrosis</d>
+<g>Nuclear factor erythroid 2-related factor 2</g> nuclear translocation induces <d>myofibroblastic dedifferentiation</d> in <d>idiopathic pulmonary fibrosis</d>
+Cytokine gene polymorphisms and BALF cytokine levels in <d>interstitial lung diseases</d>
+<g>BARD1</g> mediates <g>TGF-b</g> signaling in <d>pulmonary fibrosis</d>
+Autophagy in <d>idiopathic pulmonary fibrosis</d>
+MS80, a novel sulfated oligosaccharide, inhibits <d>pulmonary fibrosis</d> by targeting <g>TGF-beta1</g> both in vitro and in vivo
+Protective role of gambogic acid in experimental <d>pulmonary fibrosis</d> in vitro and in vivo
+Sorafenib ameliorates bleomycin-induced <d>pulmonary fibrosis</d>: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation
+Expression of <g>suppressor of cytokine signaling 1</g> in the peripheral blood of patients with <d>idiopathic pulmonary fibrosis</d>
+Profibrotic role of <g>miR-154</g> in <d>pulmonary fibrosis</d>
+Anchorage-independent colony growth of pulmonary fibroblasts derived from fibrotic human lung tissue
+The latent form of <g>TGFbeta(1)</g> is induced by <g>TNFalpha</g> through an <g>ERK</g> specific pathway and is <v>activated </v>by asbestos-derived reactive oxygen species in vitro and in vivo
+Differential effects of human neutrophil peptide-1 on growth factor and <g>interleukin-8</g> production by human lung fibroblasts and epithelial cells
+Effects of particulate matter from straw burning on <d>lung fibrosis</d> in mice
+<g>miR  -221</g> targets <g>HMGA2</g> to inhibit bleomycin  -induced <d>pulmonary fibrosis</d> by regulating <g>TGF  -b1</g>/<g>Smad3</g>-induced EMT
+<g>EZH2</g> enhances the differentiation of fibroblasts into myofibroblasts in <d>idiopathic pulmonary fibrosis</d>
+Abrogation of <g>TGF-beta1</g>-induced fibroblast-myofibroblast differentiation by <g>histone deacetylase</g> <u>inhibition.</u> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a devastating disease with no known effective pharmacological therapy
+<g>AKT2</g>
+<g>TGF-b</g> activation and lung <d>fibrosis</d>
+<g>TIAM1</g> inhibits lung fibroblast differentiation in <d>pulmonary fibrosis</d>
+Targeting genes for treatment in <d>idiopathic pulmonary fibrosis</d>: challenges and opportunities, promises and pitfalls
+Epithelial Cell Mitochondrial Dysfunction and <g>PINK1</g>
+<l>Release </l>of biologically active <g>TGF-beta1</g> by alveolar epithelial cells results in <d>pulmonary fibrosis</d>
+Regulation of transforming growth factor-b1-driven lung <d>fibrosis</d> by <g>galectin-3</g>
+Epigenetic <r>Regulation </r>of <g>Caveolin-1</g>
+Role of endoplasmic reticulum stress in age-related susceptibility to lung <d>fibrosis</d>
+<d>Pulmonary fibrosis</d>: pathogenesis, etiology and regulation
+<g>PPAR</g>-y ligands repress <g>TGFb</g>-induced myofibroblast differentiation by targeting the <g>PI3K</g>/<g>Akt</g> pathway: implications for therapy of <d>fibrosis</d>
+De-ubiquitinating enzyme, <g>USP11</g>, promotes <g>transforming growth factor b-1</g> signaling through stabilization of transforming growth factor b receptor II
+<g>Neutrophil elastase</g> promotes myofibroblast <d>differentiation in lung fibrosis</d>
+<g>MAP3K19</g>
+Effect of Renshen Pingfei Decoction, a traditional Chinese prescription, on <d>IPF</d> <v>induced </v>by Bleomycin in rats and <r>regulation </r>of <g>TGF-b1</g>/<g>Smad3</g>
+Alveolar epithelial cells express mesenchymal proteins in patients with <d>idiopathic pulmonary fibrosis</d>
+Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion
+[The potential role of cytokines expression in <d>idiopathic pulmonary fibrosis</d>]
+Effect of an immunotoxin to <g>folate receptor beta</g> on bleomycin-induced <d>experimental pulmonary fibrosis</d>
+<v>Elevated </v><e>expression </e>of <g>NEU1</g> sialidase in <d>idiopathic pulmonary fibrosis</d> <v>provokes </v>pulmonary collagen deposition, <d>lymphocytosis</d>, and <d>fibrosis</d>
+N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition
+<g>CUX1</g>/Wnt signaling regulates epithelial mesenchymal transition in EBV infected epithelial cells
+Pirfenidone exerts antifibrotic effects through <u>inhibition </u>of GLI transcription factors
+<g>STAT3</g>-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF
+<g>N-acetyl-L-cysteine</g> inhibits <g>TGF-beta1</g>-induced profibrotic responses in fibroblasts
+Epithelium-specific deletion of <g>TGF-b</g> receptor type II protects mice from bleomycin-induced <d>pulmonary fibrosis</d>
+<g>Renin</g> is an angiotensin-independent profibrotic mediator: role in <d>pulmonary fibrosis</d>
+Beyond <g>TGFb</g> - Novel ways to target airway and parenchymal <d>fibrosis</d>
+<g>CXCL9</g>
+<g>MiR-5100</g> targets <g>TOB2</g> to drive epithelial-mesenchymal transition associated with <v>activating </v><g>smad2/3</g> in lung epithelial cells
+The impact of <g>TGF-b</g> on lung <d>fibrosis</d>: from targeting to biomarkers
+Mast cell chymase: an indispensable instrument in the pathological symphony of <d>idiopathic pulmonary fibrosis</d>? <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a chronic, progressive and fatal <d>lung disease</d> with no known etiology and treatment options
+Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-b Induced Myofibroblast Differentiation via Prostaglandin E2
+miR-18a-5p <u>Inhibits </u>Sub-pleural Pulmonary Fibrosis by Targeting <g>TGF-b</g>
+<g>Yin yang 1</g> is a novel regulator of <d>pulmonary fibrosis</d>
+<d>Idiopathic pulmonary fibrosis</d>: pathobiology of novel approaches to treatment
+MicroRNA regulatory networks in <d>idiopathic pulmonary fibrosis</d>
+Fibroblastic foci, covered with <d>alveolar epithelia</d> exhibiting <d>epithelial-mesenchymal transition</d>, destroy <d>alveolar septa</d> by disrupting blood flow in <d>idiopathic pulmonary fibrosis</d>
+<e>Overproduction </e>of collagen and <u>diminished </u><g>SOCS1</g> <e>expression </e>are causally linked in fibroblasts from <d>idiopathic pulmonary fibrosis</d>
+<d>Lung infection</d> with gamma-herpesvirus induces progressive <d>pulmonary fibrosis</d> in Th2-biased mice
+<g>Semaphorin 7a</g>+ regulatory T cells are associated with progressive <d>idiopathic pulmonary fibrosis</d> and are implicated in transforming growth factor-b1-induced <d>pulmonary fibrosis</d>
+Increased expression of 5-hydroxytryptamine2A/B receptors in <d>idiopathic pulmonary fibrosis</d>: a rationale for therapeutic intervention
+Latent cytomegalovirus infection exacerbates experimental <d>pulmonary fibrosis</d> by <v>activating </v><g>TGF-b1</g>
+<g>Microsomal prostaglandin E synthase-1</g> <u>deficiency </u>exacerbates <d>pulmonary fibrosis</d> induced by bleomycin in mice
+Accelerated epithelial cell senescence in <d>IPF</d> and the inhibitory role of <g>SIRT6</g> in <g>TGF-b</g>-induced senescence of human bronchial epithelial cells
+<g>Transforming growth factor-beta1</g> in <d>sarcoidosis</d>
+<g>TGF-b1</g> induces <g>tissue factor</g> expression in human lung fibroblasts in a <g>PI3K</g>/<g>JNK</g>/<g>Akt</g>-dependent and <g>AP-1</g>-dependent manner
+Immunomodulation by mesenchymal stem cells in treating human <d>autoimmune disease-associated lung fibrosis</d>
+Curcumin inhibits <d>fibrosis</d>-related effects in <d>IPF</d> fibroblasts and in mice following bleomycin-induced <d>lung injury</d>
+<g>NADPH oxidase-4</g> mediates myofibroblast activation and fibrogenic responses to <d>lung injury</d>
+Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of <d>lung inflammation</d> and <d>fibrosis</d>
+Roles of p38 MAPK and <g>JNK</g> in <g>TGF-b1</g>-induced human alveolar epithelial to mesenchymal transition
+Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with <d>idiopathic pulmonary fibrosis</d>
+<u>Inhibition </u>of <g>PI3K</g> prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms
+<r>Effects </r>of doxycycline on <e>production </e>of growth factors and matrix metalloproteinases in <d>pulmonary fibrosis</d>
+Novel Mechanisms for the Antifibrotic Action of Nintedanib
+Pirfenidone inhibits myofibroblast differentiation and <d>lung fibrosis</d> development during insufficient mitophagy
+<g>VEGF</g> ameliorates pulmonary <d>hypertension</d> through inhibition of endothelial apoptosis in experimental lung <d>fibrosis</d> in rats
+<v>Increased </v><g>TGF-beta1</g> in the lungs of asbestos-exposed rats and mice: <u>reduced </u><e>expression </e>in <g>TNF-alpha</g> receptor knockout mice
+<r>Regulation </r>of <g>TGF-b</g> storage and activation in the human <d>idiopathic pulmonary fibrosis lung</d>
+<d>Microsatellite instability</d> in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of <d>idiopathic pulmonary fibrosis</d>
+miR-92a <r>regulates </r><g>TGF-b1</g>-<v>induced </v><g>WISP1</g> <e>expression </e>in <d>pulmonary fibrosis</d>
+Significant involvement of <g>CCL2</g> (<g>MCP-1</g>) in inflammatory disorders of the lung
+<g>TGF-beta</g>-induced EMT: mechanisms and implications for <d>fibrotic lung disease</d>
+The potential <r>role </r>of PDGF, <g>IGF-1</g>, <g>TGF-beta</g> <e>expression </e>in <d>idiopathic pulmonary fibrosis</d>
+<g>Connective tissue growth factor</g> <e>expression </e>and <v>induction </v>by <g>transforming growth factor-beta</g> is <u>abrogated </u>by simvastatin via a Rho signaling mechanism
+MOXIBUSTION HAS A POSITIVE EFFECT ON PULMONARY FIBROSIS: AN ALTERNATIVE APPROACH
+Molecular pathogenesis of <d>interstitial pneumonitis</d> with <g>TNF-alpha</g> transgenic mice
+The pathogenesis of <d>idiopathic pulmonary fibrosis</d>
+Participation of miR-200 in <d>pulmonary fibrosis</d>
+<g>Gremlin</g>-mediated decrease in bone morphogenetic protein signaling promotes <d>pulmonary fibrosis</d>
+Hyper-responsiveness of <d>IPF</d>/<d>UIP</d> fibroblasts: interplay between <g>TGFbeta1</g>, <g>IL-13</g> and <g>CCL2</g>

+Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast
+Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis
+y-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis
+Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells
+Anti-pulmonary fibrotic activity of salvianolic acid B was screened by a novel method based on the cyto-biophysical properties
+Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls
+Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis
+VCAM-1 is a TGF-b1 inducible gene upregulated in idiopathic pulmonary fibrosis
+Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis
+Combined inhibition of TGFb and PDGF signaling attenuates radiation-induced pulmonary fibrosis
+Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-kB in mice
+Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis
+Regulation of TGF-b storage and activation in the human idiopathic pulmonary fibrosis lung
+Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects
+Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF
+Association of HLA and cytokine gene polymorphisms with idiopathic pulmonary fibrosis
+Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis
+A translational preclinical model of interstitial pulmonary fibrosis and pulmonary hypertension: mechanistic pathways driving disease pathophysiology
+Pirfenidone for the treatment of idiopathic pulmonary fibrosis
+Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis
+Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-b signaling
+Blockade of the Wnt/b-catenin pathway attenuates bleomycin-induced pulmonary fibrosis
+Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis
+Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
+Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis
+Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis
+Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis
+Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention
+Signaling pathways and their miRNA regulators involved in the etiopathology of idiopathic pulmonary fibrosis (IPF) and hypersensitivity pneumonitis (HP)
+Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis
+Inhibitory effects of amines from Citrus reticulata on bleomycin-induced pulmonary fibrosis in rats
+Beyond TGFb - Novel ways to target airway and parenchymal fibrosis
+Elevated sL1-CAM levels in BALF and serum of IPF patients
+The potential application of strategic released apigenin from polymeric carrier in pulmonary fibrosis
+Epithelial contribution to the pro-fibrotic stiff microenvironment and myofibroblast population in lung fibrosis
+Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis
+Overproduction of collagen and diminished SOCS1 expression are causally linked in fibroblasts from idiopathic pulmonary fibrosis
+Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrophages in interstitial lung disease
+Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension
+Corilagin attenuates aerosol bleomycin-induced experimental lung injury
+Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease
+Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages
+Increased expression of protease nexin-1 in fibroblasts during idiopathic pulmonary fibrosis regulates thrombin activity and fibronectin expression
+Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)
+Microencapsulation of lefty-secreting engineered cells for pulmonary fibrosis therapy in mice
+p63 - Key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis
+Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis
+Molecular pathogenesis of interstitial pneumonitis with TNF-alpha transgenic mice
+Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions
+Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis
+Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis
+Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis
+Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis
+Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for idiopathic pulmonary fibrosis
+BAX inhibitor-1-associated V-ATPase glycosylation enhances collagen degradation in pulmonary fibrosis
+Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment
+Novel pharmacological approaches to manage interstitial lung fibrosis in the twenty-first century
+IL-4 polymorphisms, HRCT score and lung tissue markers in idiopathic pulmonary fibrosis
+Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis
+[The expressions and meanings of BMP-7 and TGF-b in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia]
+Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of b1,3-glucuronosyltransferase I in pulmonary fibrosis
+Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression
+TGF-b1 T869C polymorphism may affect susceptibility to idiopathic pulmonary fibrosis and disease severity
+Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects
+Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis
+Comparison between conventional and "clinical" assessment of experimental lung fibrosis
+Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice
+Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis
+Transforming growth factor b1 (TGFb1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis
+Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in chronic fibrosing interstitial pneumonia
+Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
+Modulation of CD11c+ lung dendritic cells in respect to TGF-b in experimental pulmonary fibrosis
+Expression of suppressor of cytokine signaling 1 in the peripheral blood of patients with idiopathic pulmonary fibrosis
+Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts
+Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis
+Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
+Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis
+N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats
+Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases
+Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
+JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study
+Ambroxol hydrochloride in the management of idiopathic pulmonary fibrosis: Clinical trials are the need of the hour
+IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis
+TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease
+Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury
+Signalling pathways from NADPH oxidase-4 to idiopathic pulmonary fibrosis
+Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis
+Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations
+Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
+Microsomal prostaglandin E synthase-1 deficiency exacerbates pulmonary fibrosis induced by bleomycin in mice
+Preventive and therapeutic effects of thymosin b4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis
+Serpin B4 isoform overexpression is associated with aberrant epithelial proliferation and lung cancer in idiopathic pulmonary fibrosis
+Dehydroepiandrosterone has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosis
+Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis
+Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis
+Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis
+Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis
+High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations
+Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis
+Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice
+Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium
+Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis
+Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice
+Reduced expression of BMP3 contributes to the development of pulmonary fibrosis and predicts the unfavorable prognosis in IIP patients
+The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis
+The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosis
+An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model
+Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients
+Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis
+Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis
+Type V collagen induced tolerance suppresses collagen deposition, TGF-b and associated transcripts in pulmonary fibrosis
+Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia
+Effects of the tumor suppressor PTEN on the pathogenesis of idiopathic pulmonary fibrosis in Chinese patients
+The impact of TGF-b on lung fibrosis: from targeting to biomarkers
+Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosis
+Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
+Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGFbeta1 expression
+Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis
+Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis
+Crosstalk between TGF-b1 and complement activation augments epithelial injury in pulmonary fibrosis
+Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis
+Current and novel drug therapies for idiopathic pulmonary fibrosis
+Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis
+Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis
+Data on CUX1 isoforms in idiopathic pulmonary fibrosis lung and systemic sclerosis skin tissue sections

+Assessment of the effect of potential antifibrotic compounds on total and aVb6 integrin-mediated TGF-b <v>activation.</v>
+Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in <d>idiopathic pulmonary fibrosis</d>
+<g>Syndecan-2</g> exerts antifibrotic effects by promoting <g>caveolin-1</g>-mediated transforming growth factor-b receptor I internalization and inhibiting transforming growth factor-b1 signaling
+Modulation of specific beta cell gene (re)expression during in vitro expansion of human pancreatic islet cells
+Amplification of <g>TGFb</g>
+[<d>Idiopathic pulmonary fibrosis</d> and <d>lung cancer</d>]
+<g>Periostin</g> promotes <d>fibrosis</d> and predicts progression in patients with <d>idiopathic pulmonary fibrosis</d>
+<g>CCN5</g> <v>overexpression </v>inhibits profibrotic phenotypes via the <g>PI3K</g>/Akt signaling pathway in lung fibroblasts isolated from patients with <d>idiopathic pulmonary fibrosis</d> and in an in vivo model of <d>lung fibrosis</d>
+<g>Extracellular superoxide dismutase</g> has a highly specific <l>localization </l>in <d>idiopathic pulmonary fibrosis</d>/<d>usual interstitial pneumonia</d>
+An ex vivo model to induce early <d>fibrosis</d>-like changes in human precision-cut lung slices
+The role of halofuginone in fibrosis: more to be explored? Fibrosis, which can be defined as an abnormal or excessive accumulation of extracellular matrix (ECM), particularly fibrillar collagens, is a key driver of progressive organ dysfunction in many inflammatory and metabolic diseases, including idiopathic pulmonary fibrosis (IPF), cirrhosis, nephropathy, and oral submucous fibrosis (OSF)
+Genomewide RNA expression profiling in lung identifies distinct signatures in <d>idiopathic pulmonary arterial hypertension</d> and <d>secondary pulmonary hypertension</d>
+Metformin <d>attenuates lung fibrosis</d> development via <g>NOX4</g> <u>suppression.</u>
+Cytokine gene polymorphisms and serum cytokine levels in patients with <d>idiopathic pulmonary fibrosis</d>
+Determining the True Selectivity Profile of av Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem
+Novel pharmacological approaches to manage <d>interstitial lung fibrosis</d> in the twenty-first century
+Lipoxin A4 Attenuates Constitutive and <g>TGF-b1</g>-Dependent Profibrotic Activity in Human Lung Myofibroblasts
+<g>Hsp90</g> <r>regulation </r>of fibroblast activation in <d>pulmonary fibrosis</d>
+<g>MiR-185</g>/<g>AKT</g> and <g>miR-29a</g>/collagen 1a pathways are <v>activated </v>in <d>IPF</d>
+<g>Wilms' tumor 1</g> (<g>Wt1</g>) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in <d>idiopathic pulmonary fibrosis</d>
+Kinase <u>inhibitors </u>fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue
+Early growth response transcription factors: key mediators of <d>fibrosis</d> and novel targets for anti-fibrotic therapy
+<g>Toll-like receptor 4</g> activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with <d>IPF</d>
+Sphingosine-1-phosphate lyase is an endogenous suppressor of <d>pulmonary fibrosis</d>: role of <g>S1P</g> signalling and autophagy
+A translational preclinical model of <d>interstitial pulmonary fibrosis</d> and <d>pulmonary hypertension</d>: mechanistic pathways driving disease pathophysiology
+<g>PI3K</g> p110y <v>overexpression </v>in <d>idiopathic pulmonary fibrosis lung</d> tissue and fibroblast cells: in vitro effects of its inhibition
+Low-dose paclitaxel ameliorates <d>pulmonary fibrosis</d> by suppressing <g>TGF-b1</g>/<g>Smad3</g> pathway via <g>miR-140</g> upregulation
+MicroRNAs in <d>idiopathic pulmonary fibrosis</d>
+Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung <d>Fibrosis</d>
+Membrane type-matrix metalloproteinases in <d>idiopathic pulmonary fibrosis</d>
+Increased <d>alveolar</d> soluble <g>annexin V</g> promotes <d>lung inflammation</d> and <d>fibrosis</d>
+<g>TGF-b1</g> <v>induces </v><g>Fstl1</g> via the <g>Smad3</g>-<g>c-Jun</g> pathway in lung fibroblasts
+[Different cytokine profiles in <d>usual interstitial pneumonia</d> and <d>nonspecific interstitial pneumonia</d>]
+Simvastatin attenuates <g>TGF-b1</g>-induced epithelial-mesenchymal transition in human alveolar epithelial cells
+<g>Aortic carboxypeptidase-like protein</g> (<g>ACLP</g>) enhances lung myofibroblast differentiation through transforming growth factor b receptor-dependent and -independent pathways
+Tubastatin ameliorates <d>pulmonary fibrosis</d> by targeting the TGFb-PI3K-<g>Akt</g> pathway
+Lung fibrotic <g>tenascin-C</g> <v>upregulation </v>is associated with other extracellular matrix proteins and <v>induced </v>by TGFb1
+Tannic acid attenuates TGF-b1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-b signaling in lung epithelial cells
+Regulation of myofibroblast differentiation by <g>miR-424</g> during epithelial-to-mesenchymal transition
+MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation
+<g>Extracellular Matrix Metalloproteinase Inducer</g> (<g>EMMPRIN</g>) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts
+<v>Increased </v>interleukin-1 receptor antagonist in <d>idiopathic pulmonary fibrosis</d>
+Targeting <g>sphingosine kinase 1</g> attenuates bleomycin-induced <d>pulmonary fibrosis</d>
+Re-evaluation of fibrogenic cytokines in <d>lung fibrosis</d>
+Defect of pro-<g>hepatocyte growth factor</g> activation by fibroblasts in <d>idiopathic pulmonary fibrosis</d>
+IPF lung fibroblasts have a senescent phenotype
+Autophagy and <d>inflammation</d> in chronic <d>respiratory disease</d>
+The profibrotic cytokine <g>transforming growth factor-b1</g> increases endothelial progenitor cell angiogenic properties
+Expression of <g>150-kDa oxygen-regulated protein</g> (<g>ORP150</g>) stimulates bleomycin-induced <d>pulmonary fibrosis and dysfunction</d> in mice
+Activated MCTC mast cells infiltrate diseased lung areas in <d>cystic fibrosis</d> and <d>idiopathic pulmonary fibrosis</d>
+The antifibrotic effects and mechanisms of microRNA-26a action in <d>idiopathic pulmonary fibrosis</d>
+Phosphatase and tensin homolog deleted on chromosome 10 contributes to phenotype transformation of fibroblasts in <d>idiopathic pulmonary fibrosis</d> via multiple pathways
+Lower expression of platelet derived growth factor is associated with better overall survival rate of patients with idiopathic nonspecific interstitial pneumonia
+Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in <d>Idiopathic Pulmonary Fibrosis</d> (<d>IPF</d>)
+Macrophage <g>Bone Morphogenic Protein Receptor 2</g> (<g>BMPR2</g>) <u>depletion </u>in <d>Idiopathic Pulmonary Fibrosis</d> (<d>IPF</d>) and Group III Pulmonary <d>Hypertension</d>
+<g>Cartilage oligomeric matrix protein</g> in <d>idiopathic pulmonary fibrosis</d>
+Negative regulation of myofibroblast differentiation by <g>PTEN</g> (Phosphatase and Tensin Homolog Deleted on chromosome 10)
+<g>SPARC</g> suppresses apoptosis of <d>idiopathic pulmonary fibrosis</d> fibroblasts through constitutive <v>activation </v>of <g>beta-catenin</g>
+Lactic acid is elevated in <d>idiopathic pulmonary fibrosis</d> and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-b
+Epithelial cell alpha3beta1 integrin links <g>beta-catenin</g> and Smad signaling to promote myofibroblast formation and <d>pulmonary fibrosis</d>
+EMT and <d>interstitial lung disease</d>: a mysterious relationship
+Epithelial stem cell exhaustion in the pathogenesis of <d>idiopathic pulmonary fibrosis</d>
+Berberine attenuates bleomycin induced <d>pulmonary toxicity</d> and <d>fibrosis</d> via <u>suppressing </u><g>NF-kB</g> dependant <g>TGF-b</g> <v>activation:</v> a biphasic experimental study
+Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the <g>TGF-b1</g> <v>mediated </v><g>Smad2/3</g> and <g>ERK1/2</g> <v>activation.</v> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a chronic and usually progressive <d>lung disease</d> and the epithelial-mesenchymal transition (EMT) may play an important role in the pathogenesis of <d>pulmonary fibrosis</d>
+<g>TGF-beta1</g> induces human alveolar epithelial to mesenchymal cell transition (EMT)
+Thalidomide prevents bleomycin-induced <d>pulmonary fibrosis</d> in mice
+Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice
+Significance of <v>elevated </v>procollagen-III-peptide and <g>transforming growth factor-beta</g> levels of bronchoalveolar lavage fluids from <d>idiopathic pulmonary fibrosis</d> patients
+<g>MiR-338</g>* targeting <g>smoothened</g> to inhibit <d>pulmonary fibrosis</d> by epithelial-mesenchymal transition
+Proteasomal regulation of <d>pulmonary fibrosis</d>
+Role for alpha3 integrin in EMT and <d>pulmonary fibrosis</d>
+<g>Lysocardiolipin acyltransferase</g> regulates <g>TGF-b</g> mediated lung fibroblast differentiation
+Differing Expression of Cytokines and <d>Tumor</d>
+Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced <d>pulmonary fibrosis</d>
+Tissue inhibitor of metalloproteinase-3 is up-regulated by <g>transforming growth factor-beta1</g> in vitro and expressed in fibroblastic foci in vivo in <d>idiopathic pulmonary fibrosis</d>
+Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with <d>Cryptogenic Organizing Pneumonia</d>
+Transforming growth factor-b <u>inhibits </u>IQ motif containing guanosine triphosphatase <v>activating </v>protein  1 <e>expression </e>in lung fibroblasts via the nuclear factor-kB signaling pathway
+Role of <d>von Hippel-Lindau</d> protein in fibroblast proliferation and <d>fibrosis</d>
+<g>X-linked inhibitor of apoptosis</g> regulates lung fibroblast resistance to Fas-mediated apoptosis
+Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts
+<r>Regulation </r>of 26S Proteasome Activity in <d>Pulmonary Fibrosis</d>
+Therapeutic targets in fibrotic pathways
+Mode of action of nintedanib in the treatment of <d>idiopathic pulmonary fibrosis</d>
+<v>Increased </v>deposition of chondroitin/dermatan sulfate glycosaminoglycan and <v>upregulation </v>of b1,3-glucuronosyltransferase I in <d>pulmonary fibrosis</d>
+Pathogenesis pathways of <d>idiopathic pulmonary fibrosis</d> in bleomycin-induced <d>lung injury</d> model in mice
+<r>Effects </r>of antifibrotic agents on <g>TGF-beta1</g>, <g>CTGF</g> and <g>IFN-gamma</g> <e>expression </e>in patients with <d>idiopathic pulmonary fibrosis</d>
+Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on <d>pulmonary fibrosis</d> in rat <d>idiopathic pulmonary fibrosis</d> models
+Epithelial-mesenchymal transition in chronic <d>hypersensitivity pneumonitis</d>
+Uncoupling of the profibrotic and hemostatic effects of <g>thrombin</g> in <d>lung fibrosis</d>
+Molecular targets in <d>pulmonary fibrosis</d>: the myofibroblast in focus
+<u>Reduced </u>transcription of the <g>Smad4</g> gene during <d>pulmonary carcinogenesis</d> in <d>idiopathic pulmonary fibrosis</d>
+Anti-fibrotic Role of aB-crystallin Inhibition in Pleural and Subpleural <d>Fibrosis</d>
+Reviews and prospectives of signaling pathway analysis in <d>idiopathic pulmonary fibrosis</d>
+Predisposition for disrepair in the aged lung
+N-acetylcysteine <u>downregulation </u>of <g>lysyl oxidase</g> activity alleviating bleomycin-induced <d>pulmonary fibrosis</d> in rats
+Evaluation of permeability alteration and epithelial-mesenchymal transition induced by <g>transforming growth factor-b1</g> in A549, NCI-H441, and Calu-3 cells: Development of an in vitro model of respiratory epithelial cells in <d>idiopathic pulmonary fibrosis</d>
+Epithelial contribution to the pro-fibrotic stiff microenvironment and myofibroblast population in lung <d>fibrosis</d>
+Interactions between <g>b-catenin</g> and <g>transforming growth factor-b</g> signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (<g>CREB)-binding protein</g> (<g>CBP</g>)
+<g>Syndecan-2</g> is a novel target of <g>insulin-like growth factor binding protein-3</g> and is <v>over-expressed </v>in <d>fibrosis</d>
+Membrane-anchored <g>Serine Protease</g> <g>Matriptase</g>
+The small heat-shock protein aB-crystallin is essential for the nuclear <l>localization </l>of <g>Smad4</g>: impact on <d>pulmonary fibrosis</d>
+Medical treatment for <d>pulmonary fibrosis</d>: current trends, concepts, and prospects
+Ambroxol hydrochloride in the management of <d>idiopathic pulmonary fibrosis</d>: Clinical trials are the need of the hour
+Combined <u>inhibition </u>of <g>TGFb</g> and PDGF signaling attenuates radiation-induced <d>pulmonary fibrosis</d>
+Diagnostic Values For Club Cell Secretory Protein (<g>CC16</g>) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema
+<e>Effects </e>of <g>thymosin b4</g> and its N-terminal fragment Ac-SDKP on <g>TGF-b</g>-treated human lung fibroblasts and in the mouse model of bleomycin-induced <d>lung fibrosis</d>
+An <u>inhibitor </u>of NADPH oxidase-4 attenuates established <d>pulmonary fibrosis</d> in a <d>rodent disease</d> model
+Human placental mesenchymal stem cells of fetal origins-alleviated <d>inflammation</d> and <d>fibrosis</d> by attenuating <g>MyD88</g> signaling in bleomycin-induced <d>pulmonary fibrosis</d> mice
+Roles for <g>insulin-like growth factor I</g> and <g>transforming growth factor-beta</g> in <d>fibrotic lung disease</d>
+Role of <g>caveolin-1</g> in <d>fibrotic diseases</d>
+Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of <d>pulmonary fibrosis</d>
+[The morphology and molecular bases of damage to the stem cell niche of respiratory acini in <d>idiopathic interstitial pneumonias</d>]
+Insulin-like growth factor binding proteins 3 and 5 are <v>overexpressed </v>in <d>idiopathic pulmonary fibrosis</d> and contribute to extracellular matrix deposition
+Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase
+Differential <e>expression </e>of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: <r>regulation </r>by alpha 4 beta 1-integrin crosslinking and <g>TGF-beta</g>
+Fibrotic myofibroblasts manifest genome-wide derangements of translational control
+The role of cytokines in human <d>lung fibrosis</d>
+Pirfenidone <u>inhibits </u><g>TGF-b1</g>-induced <e>over-expression </e>of collagen type I and <d>heat shock</d> protein 47 in A549 cells
+Sustained Activation of <g>Toll-Like Receptor 9</g>
+MiR-541-5p <r>regulates </r><d>lung fibrosis</d> by <r>targeting </r>cyclic nucleotide phosphodiesterase 1A
+<d>Autoimmunity</d> to Vimentin Is Associated with Outcomes of Patients with <d>Idiopathic Pulmonary Fibrosis</d>
+<g>TGF-beta 1</g>, but not <g>TGF-beta 2</g> or <g>TGF-beta 3</g>, is differentially present in epithelial cells of advanced <d>pulmonary fibrosis</d>: an immunohistochemical study
+<v>Increased </v><e>expression </e>of <g>protease nexin-1</g> in fibroblasts during <d>idiopathic pulmonary fibrosis</d> <r>regulates </r><g>thrombin</g> activity and <g>fibronectin</g> <e>expression.</e> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a chronic <d>diffuse lung disease</d> characterized by an accumulation of excess fibrous material in the lung
+<d>Idiopathic pulmonary fibrosis</d> in relation to gene polymorphisms of <g>transforming growth factor-b1</g> and <g>plasminogen activator inhibitor 1</g>
+<g>TNF-alpha</g>, PDGF, and <g>TGF-beta(1)</g> <e>expression </e>by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: <g>tnf-alpha</g> induces <g>TGF-beta(1)</g>

+Diagnostic Values For Club Cell Secretory Protein (CC16) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema
+Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts
+Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis
+Epithelial Cell Mitochondrial Dysfunction and PINK1 Are Induced by Transforming Growth Factor- Beta1 in Pulmonary Fibrosis
+The lncRNA H19 Mediates Pulmonary Fibrosis by Regulating the miR-196a/COL1A1 Axis
+Inhibition of PHGDH Attenuates Bleomycin-induced Pulmonary Fibrosis
+Transforming Growth Factor Beta 1 Activation, Storage, and Signaling Pathways in Idiopathic Pulmonary Fibrosis in Dogs
+Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis
+Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis
+Amplification of TGFb Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis
+Macrophage Bone Morphogenic Protein Receptor 2 (BMPR2) depletion in Idiopathic Pulmonary Fibrosis (IPF) and Group III Pulmonary Hypertension
+Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion
+Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
+Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis
+miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-b Receptor II
+Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2
+Protective Effect of Ginsenoside Rg1 on Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of Caveolin-1 and TGF-b1 Signal Pathway
+Mesenchymal Stem Cells Correct Inappropriate Epithelial-mesenchyme Relation in Pulmonary Fibrosis Using Stanniocalcin-1
+Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production
+Transforming Growth Factor (TGF)-b Promotes de Novo Serine Synthesis for Collagen Production
+Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis
+Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-b Induced Myofibroblast Differentiation via Prostaglandin E2
+Inhibition of the KCa3.1 Channel Alleviates Established Pulmonary Fibrosis in a Large Animal Model
+AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation
+Novel Mechanisms for the Antifibrotic Action of Nintedanib
+Determining the True Selectivity Profile of av Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem
+Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia
+Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin avb6 Expression
+Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis
+The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis
+MAP3K19 Is a Novel Regulator of TGF-b Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis
+Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-b1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt
+Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts: Possible Implications in Idiopathic Pulmonary Fibrosis
+Regulation of 26S Proteasome Activity in Pulmonary Fibrosis
+Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis
+The Role of PPARs in Lung Fibrosis
+Lipoxin A4 Attenuates Constitutive and TGF-b1-Dependent Profibrotic Activity in Human Lung Myofibroblasts
+Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells
+Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
+CXCL9 Regulates TGF-b1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells
+Anti-fibrotic Role of aB-crystallin Inhibition in Pleural and Subpleural Fibrosis
+Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-b and WNT7B in Human Lung Fibroblasts

+<r>Regulation </r>of human lung fibroblast <g>C1q</g>-receptors by <g>transforming growth factor-beta</g> and <g>tumor necrosis factor-alpha</g>
+High levels of <g>IL-6</g> and <g>IL-8</g> characterize early-on <d>idiopathic pulmonary fibrosis</d> acute exacerbations
+Regulation of the effects of <g>TGF-beta 1</g> by activation of latent <g>TGF-beta 1</g> and differential <e>expression </e>of <g>TGF-beta receptors (T beta R-I and T beta R-II</g>) in <d>idiopathic pulmonary fibrosis</d>
+Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in <d>idiopathic pulmonary fibrosis</d> patients
+<g>miR-9-5p</g> suppresses pro-fibrogenic transformation of fibroblasts and prevents organ <d>fibrosis</d> by targeting <g>NOX4</g> and <g>TGFBR2</g>
+Profibrotic role of <g>WNT10A</g> via <g>TGF-b</g> signaling in <d>idiopathic pulmonary fibrosis</d>
+Microarray profiling reveals <u>suppressed </u>interferon stimulated gene program in fibroblasts from scleroderma-associated <d>interstitial lung disease</d>
+<g>IL-4</g> polymorphisms, HRCT score and lung tissue markers in <d>idiopathic pulmonary fibrosis</d>
+Herpes <d>virus infection</d> is associated with vascular remodeling and <d>pulmonary hypertension</d> in <d>idiopathic pulmonary fibrosis</d>
+Microencapsulation of lefty-secreting engineered cells for <d>pulmonary fibrosis</d> therapy in mice
+Targeting of <g>Discoidin Domain Receptor 2</g> (<g>DDR2</g>) Prevents Myofibroblast Activation and Neovessel Formation During <d>Pulmonary Fibrosis</d>
+Role of <g>protease-activated receptor-2</g> in <d>idiopathic pulmonary fibrosis</d>
+<g>Chop</g>
+<g>VCAM-1</g> is a <g>TGF-b1</g> inducible gene <v>upregulated </v>in <d>idiopathic pulmonary fibrosis</d>
+<u>Suppression </u>of <g>plasminogen activator inhibitor-1</g> by RNA interference attenuates <d>pulmonary fibrosis</d>
+<g>JAK2</g> mediates <d>lung fibrosis</d>, <d>pulmonary vascular remodelling</d> and <d>hypertension</d> in <d>idiopathic pulmonary fibrosis</d>: an experimental study
+Melatonin attenuates <g>TGFb1</g>-induced epithelial-mesenchymal transition in lung alveolar epithelial cells
+<r>Deregulation </r>of selective autophagy during aging and <d>pulmonary fibrosis</d>: the role of <g>TGFb1</g>
+<g>RhoA</g> signaling <r>modulates </r><g>cyclin D1</g> <e>expression </e>in human lung fibroblasts; implications for <d>idiopathic pulmonary fibrosis</d>
+Inhibitory effect of <g>receptor for advanced glycation end products</g> (<g>RAGE</g>) on the <g>TGF-b</g>-induced alveolar epithelial to mesenchymal transition
+<e>Effects </e>of the <d>tumor</d> suppressor <g>PTEN</g> on the pathogenesis of <d>idiopathic pulmonary fibrosis</d> in Chinese patients
+Triptolide suppresses paraquat induced <d>idiopathic pulmonary fibrosis</d> by inhibiting <g>TGFB1</g>-dependent epithelial mesenchymal transition
+<g>Endothelin-1</g> <v>induces </v>alveolar epithelial-mesenchymal transition through endothelin type A receptor-<v>mediated </v><e>production </e>of <g>TGF-beta1</g>
+<g>p63</g> - Key molecule in the early phase of <d>epithelial abnormality</d> in <d>idiopathic pulmonary fibrosis</d>
+The hedgehog system machinery controls transforming growth factor-b-dependent myofibroblastic differentiation in humans: involvement in <d>idiopathic pulmonary fibrosis</d>
+<v>Upregulation </v>of <g>activin</g>-B and <g>follistatin</g> in <d>pulmonary fibrosis</d> - a translational study using human biopsies and a specific inhibitor in mouse <d>fibrosis</d> models
+<u>Inhibition </u>of the <g>KCa3.1</g>
+Current and novel drug therapies for <d>idiopathic pulmonary fibrosis</d>
+<g>Protease activated receptor-1</g> regulates macrophage-mediated cellular senescence: a risk for <d>idiopathic pulmonary fibrosis</d>
+Sphingolipids in <d>pulmonary fibrosis</d>
+Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts
+Pirfenidone for the treatment of <d>idiopathic pulmonary fibrosis</d>
+The anti-fibrotic effect of <u>inhibition </u>of <g>TGFb</g>-<g>ALK5</g> signalling in experimental <d>pulmonary fibrosis</d> in mice is attenuated in the presence of concurrent y-herpesvirus infection
+Angiotensin-<g>TGF-beta</g> 1 crosstalk in human <d>idiopathic pulmonary fibrosis</d>: autocrine mechanisms in myofibroblasts and macrophages
+SNAI transcription factors mediate epithelial-mesenchymal transition in <d>lung fibrosis</d>
+<g>MiR-338</g>* suppresses fibrotic pathogenesis in <d>pulmonary fibrosis</d> through targeting <g>LPA1</g>
+BALF N-acetylglucosaminidase and <g>beta-galactosidase</g> activities in <d>idiopathic pulmonary fibrosis</d>
+<g>Th1</g>/Th2 cytokine gene polymorphisms in patients with <d>idiopathic pulmonary fibrosis</d>
+Transforming Growth Factor (TGF)-b Promotes de Novo Serine Synthesis for Collagen <e>Production.</e> <g>TGF-b</g> <v>promotes </v>excessive collagen deposition in <d>fibrotic diseases</d> such as <d>idiopathic pulmonary fibrosis</d> (<d>IPF</d>)
+The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--b1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells
+<g>Transcription factor GATA-6</g> is <e>expressed </e>in quiescent myofibroblasts in <d>idiopathic pulmonary fibrosis</d>
+Epithelial-to-mesenchymal transition and its role in <g>EGFR</g>-mutant <d>lung adenocarcinoma</d> and <d>idiopathic pulmonary fibrosis</d>

+FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis
+Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent
+miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF
+Hsp90 regulation of fibroblast activation in pulmonary fibrosis
+MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells
+Tubastatin ameliorates pulmonary fibrosis by targeting the TGFb-PI3K-Akt pathway
+Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung
+Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts
+Effects of particulate matter from straw burning on lung fibrosis in mice
+BARD1 mediates TGF-b signaling in pulmonary fibrosis
+Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis
+Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition
+Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis
+Mechanisms of fibrosis in coal workers' pneumoconiosis
+Effect of substrate stiffness on pulmonary fibroblast activation by TGF-b
+Role for alpha3 integrin in EMT and pulmonary fibrosis
+Shikonin suppresses pulmonary fibroblasts proliferation and activation by regulating Akt and p38 MAPK signaling pathways
+Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis
+Molecular targets in pulmonary fibrosis: the myofibroblast in focus
+miR-92a regulates TGF-b1-induced WISP1 expression in pulmonary fibrosis
+Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis
+Increased alveolar soluble annexin V promotes lung inflammation and fibrosis
+Re-evaluation of fibrogenic cytokines in lung fibrosis
+Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2
+A critical role for the mTORC2 pathway in lung fibrosis
+Fibrotic myofibroblasts manifest genome-wide derangements of translational control
+Inhibition and role of let-7d in idiopathic pulmonary fibrosis
+Rapamycin increases CCN2 expression of lung fibroblasts via phosphoinositide 3-kinase
+Predisposition for disrepair in the aged lung
+MicroRNA regulatory networks in idiopathic pulmonary fibrosis
+Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis
+Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy
+Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis
+Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis
+[Idiopathic pulmonary fibrosis and lung cancer]
+Role of caveolin-1 in fibrotic diseases
+Latent cytomegalovirus infection exacerbates experimental pulmonary fibrosis by activating TGF-b1
+Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
+TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
+Lysocardiolipin acyltransferase regulates TGF-b mediated lung fibroblast differentiation
+Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4
+[Potential role of cytokines in idiopathic pulmonary fibrosis]
+The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis
+Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10
+Therapeutic targets in fibrotic pathways
+Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis
+Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
+Profibrotic role of WNT10A via TGF-b signaling in idiopathic pulmonary fibrosis
+microRNA-1343 attenuates pathways of fibrosis by targeting the TGF-b receptors
+Effect of Renshen Pingfei Decoction, a traditional Chinese prescription, on IPF induced by Bleomycin in rats and regulation of TGF-b1/Smad3
+M2 macrophages induce EMT through the TGF-b/Smad2 signaling pathway
+miR  -221 targets HMGA2 to inhibit bleomycin  -induced pulmonary fibrosis by regulating TGF  -b1/Smad3-induced EMT
+Autophagy in idiopathic pulmonary fibrosis
+Overexpression of Sulf2 in idiopathic pulmonary fibrosis
+Matrix metalloproteinase (MMP)-19 deficient fibroblasts display a profibrotic phenotype
+[Pulmonary fibrosis--a therapeutic dilemma?]
+Signaling pathways in the epithelial origins of pulmonary fibrosis
+FGF-1 reverts epithelial-mesenchymal transition induced by TGF-{beta}1 through MAPK/ERK kinase pathway
+Participation of miR-200 in pulmonary fibrosis
+Proteasomal regulation of pulmonary fibrosis
+Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation
+The JAK2 pathway is activated in idiopathic pulmonary fibrosis
+Human lung myofibroblast TGFb1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channels
+Transforming growth factor-beta1 in sarcoidosis
+The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis
+Cytokines in human lung fibrosis
+MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation
+Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis
+Cytokine gene polymorphisms in idiopathic pulmonary fibrosis
+Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis
+Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFb-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis
+Cub domain containing protein 1 (CDCP1) negatively regulates TGFb signaling and myofibroblast differentiation
+The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-b1 pathway in human lung fibroblasts
+N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition
+Pulmonary fibrosis: pathogenesis, etiology and regulation
+Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2
+Profibrotic role of miR-154 in pulmonary fibrosis
+miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways
+Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-b1/Smad3 pathway via miR-140 upregulation
+IPF lung fibroblasts have a senescent phenotype
+MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition
+N-acetyl-L-cysteine inhibits TGF-beta1-induced profibrotic responses in fibroblasts
+Sphingolipids in pulmonary fibrosis
+Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways
+Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis
+BALF N-acetylglucosaminidase and beta-galactosidase activities in idiopathic pulmonary fibrosis
+Transglutaminase 2 and its role in pulmonary fibrosis
+The role of cytokines in human lung fibrosis
+miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2
+Pleural mesothelial cells in pleural and lung diseases
+[Different cytokine profiles in usual interstitial pneumonia and nonspecific interstitial pneumonia]
+Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis
+Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFb1
+MiR-338* suppresses fibrotic pathogenesis in pulmonary fibrosis through targeting LPA1
+Metformin attenuates lung fibrosis development via NOX4 suppression
+Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF)
+The pathogenesis of idiopathic pulmonary fibrosis
+Interstitial fibrosis and growth factors
+TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis
+Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis
+Leucine-rich a-2 glycoprotein promotes lung fibrosis by modulating TGF-b signaling in fibroblasts
+MiR-541-5p regulates lung fibrosis by targeting cyclic nucleotide phosphodiesterase 1A
+Role of von Hippel-Lindau protein in fibroblast proliferation and fibrosis
+miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
+miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis
+TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice
+Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7
+STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF
+TGF-b1 induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts
+Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes
+Epithelial-mesenchymal transition in chronic hypersensitivity pneumonitis
+HSP27 regulates TGF-b mediated lung fibroblast differentiation through the Smad3 and ERK pathways
+Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
+[A role for mesothelial cells in the genesis of idiopathic pulmonary fibrosis?]
+Pathogenesis of idiopathic pulmonary fibrosis
+SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis
+TGF-b activation and lung fibrosis
+Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice
+[The potential role of cytokines expression in idiopathic pulmonary fibrosis]
+Autophagy and inflammation in chronic respiratory disease
+Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo
+Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis
+Membrane type-matrix metalloproteinases in idiopathic pulmonary fibrosis
+Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1
+Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFb1
+EMT and interstitial lung disease: a mysterious relationship
+Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
+Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
+MicroRNAs in idiopathic pulmonary fibrosis
+Yin yang 1 is a novel regulator of pulmonary fibrosis
+Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition
+Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10)

+M2 macrophages <v>induce </v><g>EMT</g> through the <g>TGF-b</g>/<g>Smad2</g> signaling pathway
+Up-regulation of heparan sulfate 6-O-sulfation in <d>idiopathic pulmonary fibrosis</d>
+Comparison between conventional and "clinical" assessment of experimental lung <d>fibrosis</d>
+Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by <r>regulating </r><g>Nrf2</g>/<g>Bach1</g> equilibrium
+Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with <d>Idiopathic Pulmonary Fibrosis</d>
+<u>Inhibition </u>of <g>HSP27</g> blocks <d>fibrosis</d> development and EMT features by promoting <g>Snail</g> degradation
+Signalling pathways from NADPH oxidase-4 to <d>idiopathic pulmonary fibrosis</d>
+<r>Effects </r>of a leukotriene B4 receptor antagonist on bleomycin-induced <d>pulmonary fibrosis</d>
+Activated human T lymphocytes inhibit <g>TGFb</g>-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2
+The Role of PPARs in Lung <d>Fibrosis</d>
+Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a <g>TGF-b1</g>-dependent mechanism
+The potential application of strategic released apigenin from polymeric carrier in pulmonary fibrosis
+<v>Overexpression </v>of <g>Sulf2</g> in <d>idiopathic pulmonary fibrosis</d>
+Essential role for the <g>ATG4B</g> protease and autophagy in bleomycin-induced <d>pulmonary fibrosis</d>
+<g>Bone morphogenetic protein-4</g> inhibitor <g>gremlin</g> is <v>overexpressed </v>in <d>idiopathic pulmonary fibrosis</d>
+Smooth muscle alpha-actin <e>expression </e>and myofibroblast differentiation by <g>TGFbeta</g> are <v>dependent </v>upon <g>MK2</g>
+The K+ channel <g>KCa3.1</g> as a novel target for <d>idiopathic pulmonary fibrosis</d>
+<g>Spiruchostatin A</g> inhibits proliferation and differentiation of fibroblasts from patients with <d>pulmonary fibrosis</d>
+<v>Elevated </v><g>sL1</g>-CAM levels in BALF and serum of <d>IPF</d> patients
+Lung myofibroblasts are characterized by <u>down-regulated </u><g>cyclooxygenase-2</g> and its main metabolite, prostaglandin E2
+Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells
+Microarray identifies ADAM family members as key responders to <g>TGF-beta1</g> in alveolar epithelial cells
+Titration of non-replicating adenovirus as a vector for <v>transducing </v>active <g>TGF-beta1</g> gene <e>expression </e>causing <d>inflammation</d> and fibrogenesis in the lungs of C57BL/6 mice
+Effect of substrate stiffness on pulmonary fibroblast activation by <g>TGF-b</g>
+A critical role for the <g>mTORC2</g> pathway in <d>lung fibrosis</d>
+Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways
+<g>TGF-beta</g> driven lung <d>fibrosis</d> is macrophage dependent and blocked by Serum amyloid P
+Exercise <u>Reduces </u>Lung <d>Fibrosis</d>
+Sputum biomarkers in <d>IPF</d>: Evidence for raised gene <e>expression </e>and protein level of <g>IGFBP-2</g>, <g>IL-8</g> and <g>MMP-7</g>
+<g>Forkhead Box F1</g> (<g>FOXF1</g>) <u>represses </u>cell growth, COL1 and <g>ARPC2</g> <e>expression </e>in lung fibroblasts in vitro
+<g>MicroRNA-29c</g> regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts
+<g>Prostaglandin F(2alpha) receptor</g> signaling facilitates bleomycin-induced <d>pulmonary fibrosis</d> independently of transforming growth factor-beta
+<e>Expression </e>of mucosa-related integrin alphaEbeta7 on <d>alveolar T</d> cells in <d>interstitial lung diseases</d>
+Cytoskeletal protein modulation in <d>pulmonary alveolar myofibroblasts</d> during <d>idiopathic pulmonary fibrosis</d>
+<g>Transglutaminase 2</g> and its role in <d>pulmonary fibrosis</d>
+Sunitinib, a Small-Molecule Kinase <u>Inhibitor,</u>
+Fibroblasts from <d>idiopathic pulmonary fibrosis</d> and normal lungs differ in growth rate, apoptosis, and tissue <u>inhibitor </u>of metalloproteinases <e>expression.</e> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a <d>chronic lung disorder</d> characterized by fibroblast proliferation and extracellular matrix accumulation
+<g>WISP1</g> mediates <g>IL-6</g>-dependent proliferation in primary human lung fibroblasts
+<d>Idiopathic pulmonary fibrosis</d>: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers
+Amplified canonical transforming growth factor-b signalling<i>via</i><d>heat shock</d> protein 90 in <d>pulmonary fibrosis</d>
+<v>Upregulation </v>of alveolar <e>levels </e>of activin B, but not activin A, in lungs of west highland white terriers with <d>idiopathic pulmonary fibrosis</d> and <d>diffuse alveolar damage</d>
+Absence of <g>Thy-1</g> results in <g>TGF-b</g> induced <g>MMP-9</g> expression and confers a profibrotic phenotype to human lung fibroblasts
+Shikonin suppresses pulmonary fibroblasts proliferation and activation by <r>regulating </r><g>Akt</g> and <g>p38</g>
+<g>TRPV4</g> mediates myofibroblast differentiation and <d>pulmonary fibrosis</d> in mice
+Modulation of <g>CD11c</g>+ lung dendritic cells in respect to <g>TGF-b</g> in experimental <d>pulmonary fibrosis</d>
+Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced <d>pulmonary fibrosis progression</d>
+Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion
+Induction of epithelial-mesenchymal transition in alveolar epithelial cells by <g>transforming growth factor-beta1</g>: potential role in <d>idiopathic pulmonary fibrosis</d>
+Recent advances in molecular targets and treatment of <d>idiopathic pulmonary fibrosis</d>: focus on <g>TGFbeta</g> signaling and the myofibroblast
+<g>Bone morphogenetic protein</g>-inducer tilorone identified by high-throughput screening is antifibrotic in vivo
+Pleural mesothelial cell differentiation and invasion in <d>fibrogenic lung injury</d>
+Studies of <g>hepatocyte growth factor</g> in bronchoalveolar lavage fluid in chronic <d>interstitial lung diseases</d>
+Cytokine gene polymorphisms in <d>idiopathic pulmonary fibrosis</d>
+<g>Cub domain containing protein 1</g> (<g>CDCP1</g>) negatively regulates TGFb signaling and myofibroblast differentiation
+Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in chronic fibrosing <d>interstitial pneumonia</d>
+Mechanisms of <d>fibrosis</d> in <d>coal workers' pneumoconiosis</d>
+Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts
+Are mast cells instrumental for <d>fibrotic diseases</d>? <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a <d>fatal lung disorder</d> of unknown etiology characterized by accumulation of lung fibroblasts and extracellular matrix deposition, ultimately leading to compromised tissue architecture and lung function capacity
+<g>miR</g>-323a-3p regulates <d>lung fibrosis</d> by targeting multiple profibrotic pathways
+<g>TGF-b1</g> <v>stimulates </v><g>HDAC4</g> nucleus-to-cytoplasm <l>translocation </l>and <g>NADPH oxidase 4</g>-derived reactive oxygen species in normal human lung fibroblasts
+Effects of <d>cigarette smoke extract</d> on A549 cells and human lung fibroblasts treated with <g>transforming growth factor-beta1</g> in a coculture system
+MicroRNA-326 regulates profibrotic functions of transforming growth factor-b in <d>pulmonary fibrosis</d>
+Differential mRNA expression of <g>insulin-like growth factor-1</g> splice variants in patients with <d>idiopathic pulmonary fibrosis</d> and <d>pulmonary sarcoidosis</d>
+Pathogenesis of <d>idiopathic pulmonary fibrosis</d>
+<u>Reduced </u><g>Ets Domain-containing Protein Elk1</g>
+Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells
+<g>HSP27</g> regulates <g>TGF-b</g> mediated lung fibroblast differentiation through the <g>Smad3</g> and <g>ERK</g> pathways
+<e>Expression </e>of <g>WNT5A</g> in <d>Idiopathic Pulmonary Fibrosis</d> and Its <r>Control </r>by <g>TGF-b</g> and <g>WNT7B</g> in Human Lung Fibroblasts
+<g>FGF-1</g> reverts epithelial-mesenchymal transition induced by <g>TGF-{beta}1</g> through MAPK/ERK kinase pathway
+Type II alveolar epithelial cells and interstitial fibroblasts express <g>connective tissue growth factor</g> in <d>IPF</d>
+<g>Transforming growth factor b1</g> (<g>TGFb1</g>)-induced CD44V6-<g>NOX4</g> signaling in pathogenesis of <d>idiopathic pulmonary fibrosis</d>
+Pleural mesothelial cells in <d>pleural and lung diseases</d>
+<d>Idiopathic pulmonary fibrosis</d>: an altered fibroblast proliferation linked to <d>cancer</d> biology
+<g>Caveolin-1</g>: a critical regulator of <d>lung fibrosis</d> in <d>idiopathic pulmonary fibrosis</d>
+<g>Cthrc1</g> lowers pulmonary collagen associated with bleomycin-induced <d>fibrosis</d> and protects lung function
+Wnt coreceptor <g>Lrp5</g> is a driver of <d>idiopathic pulmonary fibrosis</d>
+Protective Effect of Ginsenoside Rg1 on Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of <g>Caveolin-1</g> and <g>TGF-b1</g>
+The <g>JAK2</g> pathway is activated in <d>idiopathic pulmonary fibrosis</d>
+<g>miR-31</g> is a negative regulator of fibrogenesis and <d>pulmonary fibrosis</d>
+<u>Defect </u>of <g>hepatocyte growth factor</g> <l>secretion </l>by fibroblasts in <d>idiopathic pulmonary fibrosis</d>
+<g>NOX4</g>/NADPH oxidase <e>expression </e>is <v>increased </v>in pulmonary fibroblasts from patients with <d>idiopathic pulmonary fibrosis</d> and mediates <g>TGFbeta1</g>-induced fibroblast differentiation into myofibroblasts
+Matrix regulation of <d>idiopathic pulmonary fibrosis</d>: the role of enzymes
+Rapamycin <v>increases </v><g>CCN2</g> <e>expression </e>of lung fibroblasts via <g>phosphoinositide 3-kinase</g>
+[The expressions and meanings of <g>BMP-7</g> and <g>TGF-b</g> in <d>idiopathic pulmonary fibrosis</d> and <d>idiopathic nonspecific interstitial pneumonia</d>]
+Human lung myofibroblast <g>TGFb1</g>-dependent <g>Smad2/3</g> signalling is Ca(2+)-dependent and <r>regulated </r>by <g>KCa3.1</g>
+[A role for mesothelial cells in the genesis of <d>idiopathic pulmonary fibrosis</d>?]
+Antifibrotic effects of <g>cyclosporine A</g> on <g>TGF-b1</g>-treated lung fibroblasts and lungs from bleomycin-treated mice: role of <g>hypoxia-inducible factor-1a</g>
+<g>TGF-beta 1</g> as an enhancer of Fas-mediated apoptosis of lung epithelial cells
+Mesenchymal Stem Cells Correct Inappropriate Epithelial-mesenchyme Relation in <d>Pulmonary Fibrosis</d>
+Proliferation of pulmonary interstitial fibroblasts is mediated by <g>transforming growth factor-beta1</g>-induced release of extracellular <g>fibroblast growth factor-2</g> and <p>phosphorylation </p>of <g>p38</g>
+Prognostic factors for <d>idiopathic pulmonary fibrosis</d>: clinical, physiologic, pathologic, and molecular aspects
+Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts
+<g>Secreted protein acidic and rich in cysteine</g> (<g>SPARC</g>) is upregulated by transforming growth factor (TGF)-b and is required for <g>TGF-b</g>-induced hydrogen peroxide production in fibroblasts
+The lncRNA <g>H19</g>
+<e>Contribution </e>of the anaphylatoxin receptors, <g>C3aR</g> and <g>C5aR</g>, to the pathogenesis of <d>pulmonary fibrosis</d>
+Corilagin attenuates aerosol bleomycin-induced experimental <d>lung injury</d>
+[Potential role of cytokines in <d>idiopathic pulmonary fibrosis</d>]
+Protective role of andrographolide in bleomycin-induced <d>pulmonary fibrosis</d> in mice
+<g>Serpin B4</g> isoform overexpression is associated with aberrant epithelial proliferation and <d>lung cancer</d> in <d>idiopathic pulmonary fibrosis</d>
+Interstitial <d>fibrosis</d> and growth factors
+<u>Blockade </u>of the Wnt/b-catenin pathway attenuates bleomycin-induced <d>pulmonary fibrosis</d>
+Control of virus reactivation arrests pulmonary herpesvirus-induced <d>fibrosis</d> in IFN-gamma receptor-<u>deficient </u>mice
+Interplay between <g>RAGE</g>, <g>CD44</g>, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells
+Antifibrotic properties of receptor for advanced glycation end products in <d>idiopathic pulmonary fibrosis</d>
+Dysregulated Collagen Homeostasis by Matrix Stiffening and <g>TGF-b1</g> in Fibroblasts from <d>Idiopathic Pulmonary Fibrosis</d>
+TGF-b1 T869C polymorphism may affect susceptibility to <d>idiopathic pulmonary fibrosis</d> and disease severity
+Anti-pulmonary fibrotic activity of salvianolic acid B was screened by a novel method based on the cyto-biophysical properties
+Cytokines in human <d>lung fibrosis</d>
+<e>Expression </e>of <g>RXFP1</g>
+Plasma <g>CCN2</g> (connective tissue growth factor; <g>CTGF</g>) is a potential biomarker in <d>idiopathic pulmonary fibrosis</d> (<d>IPF</d>)
+Azithromycin attenuates myofibroblast differentiation and lung <d>fibrosis</d> development through <d>proteasomal degradation</d> of <g>NOX4</g>
+Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of <d>idiopathic pulmonary fibrosis</d>
+Crosstalk between <g>TGF-b1</g> and complement activation augments epithelial <d>injury in pulmonary fibrosis</d>
+Bleomycin and <g>IL-1beta</g>-mediated <d>pulmonary fibrosis</d> is <g>IL-17A</g> dependent
+miR-199a-5p Is <v>upregulated </v>during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting <g>caveolin-1</g>
+Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental <d>pulmonary fibrosis</d>
+Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during <d>idiopathic pulmonary fibrosis</d>
+<g>Transforming growth factor beta1</g> induces epithelial-to-mesenchymal transition of A549 cells
+The anti-fibrotic effects of microRNA-153 by <r>targeting </r><g>TGFBR-2</g> in <d>pulmonary fibrosis</d>
+<u>Defective </u>histone acetylation is <r>responsible </r>for the <u>diminished </u><e>expression </e>of <g>cyclooxygenase 2</g> in <d>idiopathic pulmonary fibrosis</d>
+y-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates <d>established murine lung fibrosis</d>
+Inhibition and role of <g>let-7d</g> in <d>idiopathic pulmonary fibrosis</d>
+Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to <g>TGF-beta1</g> in vitro
+Association of HLA and cytokine gene polymorphisms with <d>idiopathic pulmonary fibrosis</d>
+Signaling pathways and their miRNA regulators involved in the etiopathology of <d>idiopathic pulmonary fibrosis</d> (<d>IPF</d>) and <d>hypersensitivity pneumonitis</d> (<d>HP</d>)
+<g>miR-21</g> mediates fibrogenic activation of pulmonary fibroblasts and lung <d>fibrosis</d>
+Inhibitory effects of amines from Citrus reticulata on bleomycin-induced <d>pulmonary fibrosis</d> in rats
+Thalidomide <u>reduces </u><g>IL-18</g>, <g>IL-8</g> and <g>TNF-alpha</g> <l>release </l>from alveolar macrophages in <d>interstitial lung disease</d>
+Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced <d>pulmonary fibrosis</d> in rats: Decisive role of <g>Bax</g>, <g>Nrf2</g>, <g>NF-kB</g>, <g>Muc5ac</g>, <g>TNF-a</g> and <g>IL-1b</g>
+The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in <d>Pulmonary Fibrosis</d>
+The role of microRNA-155/liver X receptor pathway in experimental and <d>idiopathic pulmonary fibrosis</d>
+<g>Cysteine-rich protein 1</g> is regulated by <g>transforming growth factor-b1</g> and expressed in lung <d>fibrosis</d>

+#Cluster:  1
+3_s   3
+17_s   17
+33_s   33
+42_s   42
+43_s   43
+59_s   59
+66_s   66
+82_s   82
+84_s   84
+100_s   100
+123_s   123
+124_s   124
+132_s   131
+136_s   135
+137_s   136
+148_s   147
+188_s   186
+196_s   194
+216_s   214
+219_s   217
+226_s   224
+227_s   225
+229_s   227
+230_s   228
+234_s   232
+238_s   236
+244_s   242
+245_s   243
+269_s   266
+275_s   272
+281_s   278
+287_s   284
+290_s   287
+301_s   297
+302_s   298
+303_s   299
+315_s   311
+332_s   328
+350_s   346
+361_s   357
+366_s   362
+379_s   375
+415_s   411
+421_s   417
+444_s   440
+445_s   441
+446_s   442
+453_s   449
+#Cluster:  2 
+6_s   6
+18_s   18
+24_s   24
+25_s   25
+29_s   29
+37_s   37
+38_s   38
+44_s   44
+47_s   47
+55_s   55
+65_s   65
+69_s   69
+70_s   70
+71_s   71
+72_s   72
+79_s   79
+81_s   81
+86_s   86
+92_s   92
+94_s   94
+101_s   101
+102_s   102
+104_s   104
+110_s   110
+112_s   112
+115_s   115
+118_s   118
+120_s   120
+127_s   126
+128_s   127
+130_s   129
+144_s   143
+146_s   145
+156_s   155
+161_s   160
+164_s   163
+166_s   165
+169_s   168
+179_s   177
+182_s   180
+186_s   184
+189_s   187
+192_s   190
+195_s   193
+204_s   202
+205_s   203
+208_s   206
+217_s   215
+221_s   219
+222_s   220
+223_s   221
+225_s   223
+233_s   231
+236_s   234
+241_s   239
+242_s   240
+247_s   245
+260_s   257
+262_s   259
+265_s   262
+272_s   269
+278_s   275
+279_s   276
+280_s   277
+284_s   281
+289_s   286
+297_s   293
+300_s   296
+307_s   303
+308_s   304
+310_s   306
+316_s   312
+318_s   314
+320_s   316
+326_s   322
+330_s   326
+335_s   331
+336_s   332
+340_s   336
+348_s   344
+352_s   348
+353_s   349
+355_s   351
+357_s   353
+371_s   367
+383_s   379
+384_s   380
+392_s   388
+399_s   395
+402_s   398
+408_s   404
+411_s   407
+413_s   409
+414_s   410
+418_s   414
+419_s   415
+424_s   420
+428_s   424
+429_s   425
+433_s   429
+438_s   434
+440_s   436
+447_s   443
+450_s   446
+#Cluster:  3 
+1_s   1
+5_s   5
+7_s   7
+8_s   8
+10_s   10
+12_s   12
+13_s   13
+14_s   14
+16_s   16
+20_s   20
+22_s   22
+23_s   23
+28_s   28
+31_s   31
+34_s   34
+48_s   48
+49_s   49
+54_s   54
+58_s   58
+64_s   64
+67_s   67
+74_s   74
+75_s   75
+80_s   80
+83_s   83
+87_s   87
+88_s   88
+89_s   89
+90_s   90
+91_s   91
+93_s   93
+98_s   98
+106_s   106
+109_s   109
+117_s   117
+138_s   137
+141_s   140
+142_s   141
+147_s   146
+149_s   148
+150_s   149
+159_s   158
+162_s   161
+163_s   162
+165_s   164
+171_s   169
+174_s   172
+177_s   175
+184_s   182
+190_s   188
+197_s   195
+198_s   196
+199_s   197
+203_s   201
+210_s   208
+214_s   212
+215_s   213
+220_s   218
+237_s   235
+239_s   237
+240_s   238
+243_s   241
+246_s   244
+248_s   246
+250_s   248
+251_s   249
+253_s   250
+254_s   251
+255_s   252
+256_s   253
+264_s   261
+268_s   265
+273_s   270
+286_s   283
+291_s   288
+293_s   289
+295_s   291
+298_s   294
+299_s   295
+305_s   301
+313_s   309
+314_s   310
+317_s   313
+322_s   318
+325_s   321
+328_s   324
+333_s   329
+343_s   339
+345_s   341
+347_s   343
+349_s   345
+354_s   350
+356_s   352
+360_s   356
+362_s   358
+363_s   359
+364_s   360
+365_s   361
+367_s   363
+368_s   364
+372_s   368
+374_s   370
+375_s   371
+376_s   372
+377_s   373
+378_s   374
+380_s   376
+387_s   383
+388_s   384
+390_s   386
+391_s   387
+398_s   394
+401_s   397
+403_s   399
+407_s   403
+409_s   405
+416_s   412
+420_s   416
+431_s   427
+437_s   433
+442_s   438
+443_s   439
+448_s   444
+451_s   447
+452_s   448
+#Cluster:  4
+9_s   9
+19_s   19
+21_s   21
+26_s   26
+32_s   32
+39_s   39
+52_s   52
+73_s   73
+77_s   77
+95_s   95
+107_s   107
+113_s   113
+125_s   125
+129_s   128
+131_s   130
+145_s   144
+153_s   152
+158_s   157
+172_s   170
+175_s   173
+180_s   178
+200_s   198
+202_s   200
+207_s   205
+224_s   222
+228_s   226
+231_s   229
+259_s   256
+263_s   260
+274_s   271
+283_s   280
+288_s   285
+306_s   302
+321_s   317
+323_s   319
+334_s   330
+359_s   355
+382_s   378
+395_s   391
+417_s   413
+434_s   430
+454_s   450
+#Cluster:  5
+11_s   11
+27_s   27
+30_s   30
+36_s   36
+40_s   40
+46_s   46
+53_s   53
+57_s   57
+60_s   60
+62_s   62
+63_s   63
+78_s   78
+96_s   96
+99_s   99
+114_s   114
+122_s   122
+134_s   133
+135_s   134
+154_s   153
+155_s   154
+160_s   159
+167_s   166
+168_s   167
+173_s   171
+187_s   185
+194_s   192
+206_s   204
+211_s   209
+213_s   211
+249_s   247
+257_s   254
+258_s   255
+267_s   264
+271_s   268
+276_s   273
+282_s   279
+285_s   282
+296_s   292
+319_s   315
+346_s   342
+351_s   347
+358_s   354
+385_s   381
+386_s   382
+389_s   385
+396_s   392
+405_s   401
+423_s   419
+427_s   423
+430_s   426
+449_s   445
+455_s   451
+#Cluster:  6
+2_s   2
+4_s   4
+15_s   15
+35_s   35
+41_s   41
+45_s   45
+50_s   50
+51_s   51
+56_s   56
+61_s   61
+68_s   68
+76_s   76
+85_s   85
+97_s   97
+103_s   103
+105_s   105
+108_s   108
+111_s   111
+116_s   116
+119_s   119
+121_s   121
+133_s   132
+139_s   138
+140_s   139
+143_s   142
+151_s   150
+152_s   151
+157_s   156
+176_s   174
+178_s   176
+181_s   179
+183_s   181
+185_s   183
+191_s   189
+193_s   191
+201_s   199
+209_s   207
+212_s   210
+218_s   216
+232_s   230
+235_s   233
+261_s   258
+266_s   263
+270_s   267
+277_s   274
+294_s   290
+304_s   300
+309_s   305
+311_s   307
+312_s   308
+324_s   320
+327_s   323
+329_s   325
+331_s   327
+337_s   333
+338_s   334
+339_s   335
+341_s   337
+342_s   338
+344_s   340
+369_s   365
+370_s   366
+373_s   369
+381_s   377
+393_s   389
+394_s   390
+397_s   393
+400_s   396
+404_s   400
+406_s   402
+410_s   406
+412_s   408
+422_s   418
+425_s   421
+426_s   422
+432_s   428
+435_s   431
+436_s   432
+439_s   435
+441_s   437

+Tissue inhibitor of metalloproteinase-3 is up-regulated by transforming growth factor-beta1 in vitro and expressed in fibroblastic foci in vivo in idiopathic pulmonary fibrosis
+Upregulation of alveolar levels of activin B, but not activin A, in lungs of west highland white terriers with idiopathic pulmonary fibrosis and diffuse alveolar damage
+Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor
+Upregulation of activin-B and follistatin in pulmonary fibrosis - a translational study using human biopsies and a specific inhibitor in mouse fibrosis models
+Resveratrol inhibits transforming growth factor-b-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration
+Interactions between b-catenin and transforming growth factor-b signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP)
+Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-b receptor I internalization and inhibiting transforming growth factor-b1 signaling
+Lower expression of platelet derived growth factor is associated with better overall survival rate of patients with idiopathic nonspecific interstitial pneumonia
+TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study
+Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis
+Significance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis patients
+The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo
+Human placental mesenchymal stem cells of fetal origins-alleviated inflammation and fibrosis by attenuating MyD88 signaling in bleomycin-induced pulmonary fibrosis mice
+Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression
+Phosphatase and tensin homolog deleted on chromosome 10 contributes to phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis via multiple pathways
+Transforming growth factor-b1 downregulates vascular endothelial growth factor-D expression in human lung fibroblasts via the Jun NH2-terminal kinase signaling pathway
+The anti-fibrotic effect of inhibition of TGFb-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent y-herpesvirus infection
+Transforming growth factor-b inhibits IQ motif containing guanosine triphosphatase activating protein  1 expression in lung fibroblasts via the nuclear factor-kB signaling pathway
+De-ubiquitinating enzyme, USP11, promotes transforming growth factor b-1 signaling through stabilization of transforming growth factor b receptor II
+Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor b receptor-dependent and -independent pathways
+Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition
+Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways
+Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis
+Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism
+Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation
+NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts
+Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-b1 and plasminogen activator inhibitor 1
+Comparative study of transforming growth factor-b signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis
+Microsatellite instability in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of idiopathic pulmonary fibrosis
+Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta
+Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition
+Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-b1 in A549, NCI-H441, and Calu-3 cells: Development of an in vitro model of respiratory epithelial cells in idiopathic pulmonary fibrosis
+TGF-b1 stimulates HDAC4 nucleus-to-cytoplasm translocation and NADPH oxidase 4-derived reactive oxygen species in normal human lung fibroblasts
+Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-b
+Differential mRNA expression of insulin-like growth factor-1 splice variants in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis
+The hedgehog system machinery controls transforming growth factor-b-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis
+Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis
+Are mast cells instrumental for fibrotic diseases? Idiopathic pulmonary fibrosis (IPF) is a fatal lung disorder of unknown etiology characterized by accumulation of lung fibroblasts and extracellular matrix deposition, ultimately leading to compromised tissue architecture and lung function capacity
+The role of halofuginone in fibrosis: more to be explored? Fibrosis, which can be defined as an abnormal or excessive accumulation of extracellular matrix (ECM), particularly fibrillar collagens, is a key driver of progressive organ dysfunction in many inflammatory and metabolic diseases, including idiopathic pulmonary fibrosis (IPF), cirrhosis, nephropathy, and oral submucous fibrosis (OSF)
+CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis
+Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis? Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal lung disease with no known etiology and treatment options
+The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--b1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells
+PI3K p110y overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition
+Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase
+Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK
+Secreted protein acidic and rich in cysteine (SPARC) is upregulated by transforming growth factor (TGF)-b and is required for TGF-b-induced hydrogen peroxide production in fibroblasts
+Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-b1-induced pulmonary fibrosis
+Arsenic trioxide inhibits transforming growth factor-b1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo

+Resveratrol inhibits transforming growth factor-b-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through <g>ERK</g>/<g>Akt</g> <u>inhibition </u>and <g>PTEN</g> restoration
+Signaling pathways in the epithelial origins of <d>pulmonary fibrosis</d>
+Raised serum levels of <g>IGFBP-1</g> and <g>IGFBP-2</g> in <d>idiopathic pulmonary fibrosis</d>
+Methylation-mediated <g>BMPER</g> <e>expression </e>in fibroblast activation in vitro and lung <d>fibrosis</d> in mice in vivo
+<d>Fibrosis</d> of two: Epithelial cell-fibroblast interactions in <d>pulmonary fibrosis</d>
+Arsenic trioxide inhibits transforming growth factor-b1-induced <d>fibroblast to myofibroblast differentiation</d> in vitro and bleomycin induced lung <d>fibrosis</d> in vivo
+microRNA-1343 attenuates pathways of <d>fibrosis</d> by targeting the <g>TGF-b</g> receptors
+<g>Matrix metalloproteinase (MMP)-19</g> <u>deficient </u>fibroblasts display a profibrotic phenotype
+Comparative study of transforming growth factor-b signalling and regulatory molecules in human and canine <d>idiopathic pulmonary fibrosis</d>
+Genetic polymorphism in <g>matrix metalloproteinase-9</g> and <g>transforming growth factor-b1</g> and susceptibility to <d>combined pulmonary fibrosis</d> and <d>emphysema</d> in  a Chinese population
+Transforming growth factor-b1 downregulates <g>vascular endothelial growth factor</g>-D expression in human lung fibroblasts via the <g>Jun NH2-terminal kinase</g> signaling pathway
+<g>Ubiquitin carboxyl-terminal hydrolase-L5</g> promotes <g>TGFb-1</g> signaling by de-ubiquitinating and stabilizing <g>Smad2</g>/<g>Smad3</g> in <d>pulmonary fibrosis</d>
+Effect of pirfenidone on proliferation, <g>TGF-b</g>-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
+[Quantifying plasma levels of <g>transforming growth factor beta1</g> in <d>idiopathic pulmonary fibrosis</d>]
+The matricellular protein <g>CCN1</g> enhances <g>TGF-b1</g>/<g>SMAD3</g>-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to <d>lung injury</d>
+Bleomycin in the setting of <d>lung fibrosis</d> induction: From biological mechanisms to counteractions
+Alveolar epithelial cell injury with Epstein-Barr virus <v>upregulates </v><g>TGFbeta1</g> <e>expression.</e> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a refractory and lethal <d>interstitial lung disease</d> characterized by alveolar epithelial cells apoptosis, fibroblast proliferation, and ECM protein deposition
+Single-cell RNA sequencing identifies diverse roles of epithelial cells in <d>idiopathic pulmonary fibrosis</d>
+Data on <g>CUX1</g> isoforms in <d>idiopathic pulmonary fibrosis lung</d> and <d>systemic sclerosis</d> skin tissue sections
+<d>Idiopathic Pulmonary Fibrosis</d>: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
+Genetic partitioning of <g>interleukin-6</g> signalling in mice dissociates <g>Stat3</g> from <g>Smad3</g>-mediated <d>lung fibrosis</d>
+Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in <d>idiopathic pulmonary fibrosis</d>
+Oxidant-antioxidant imbalance as a potential contributor to the progression of human <d>pulmonary fibrosis</d>
+Increased production and immunohistochemical localization of <g>transforming growth factor-beta</g> in <d>idiopathic pulmonary fibrosis</d>
+Type V collagen induced tolerance suppresses collagen deposition, <g>TGF-b</g> and associated transcripts in <d>pulmonary fibrosis</d>
+Preventive and therapeutic effects of thymosin b4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis
+FAK-related nonkinase is a multifunctional negative regulator of <d>pulmonary fibrosis</d>
+Nitrated fatty acids reverse <d>pulmonary fibrosis</d> by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages
+Cytokine profiles in <d>idiopathic pulmonary fibrosis</d> suggest an important role for <g>TGF-beta</g> and <g>IL-10</g>
+Sphingosine-1-phosphate is increased in patients with <d>idiopathic pulmonary fibrosis</d> and mediates epithelial to mesenchymal transition
+Leucine-rich a-2 glycoprotein promotes <d>lung fibrosis</d> by modulating <g>TGF-b</g> signaling in fibroblasts
+Sustained <g>PI3K</g>
+Pirfenidone <u>inhibits </u>the <e>expression </e>of <g>HSP47</g> in <g>TGF-beta1</g>-stimulated human lung fibroblasts
+Age-driven developmental drift in the pathogenesis of <d>idiopathic pulmonary fibrosis</d>
+Endogenous <g>Semaphorin-7A</g>
+Progressive transforming growth factor beta1-induced <d>lung fibrosis</d> is blocked by an orally active <g>ALK5</g> kinase <u>inhibitor.</u> <d>Pulmonary fibrosis</d> is characterized by chronic scar formation and deposition of extracellular matrix, resulting in <d>impaired lung function</d> and <d>respiratory failure</d>
+Compromised peroxisomes in <d>idiopathic pulmonary fibrosis</d>, a vicious cycle inducing a higher fibrotic response via <g>TGF-b</g> signaling
+Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced <d>pulmonary fibrosis</d>
+Intrinsic defence capacity and therapeutic potential of natriuretic peptides in <d>pulmonary hypertension</d> associated with <d>lung fibrosis</d>
+Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for <d>idiopathic pulmonary fibrosis</d>
+BAL cytokine profile in different <d>interstitial lung diseases</d>: a focus on <d>systemic sclerosis</d>
+Matrix metalloproteinase 3 is a mediator of <d>pulmonary fibrosis</d>
+<u>Inhibition </u>of <g>PHGDH</g>
+Bleomycin induces molecular changes directly relevant to <d>idiopathic pulmonary fibrosis</d>: a model for "active" disease
+Lysyl oxidases <r>regulate </r>fibrillar collagen remodelling in idiopathic pulmonary fibrosis
+Discovery and validation of extracellular/circulating microRNAs during <d>idiopathic pulmonary fibrosis disease</d> progression
+Recombinant human <g>serum amyloid P</g> in healthy volunteers and patients with <d>pulmonary fibrosis</d>
+<g>Transforming Growth Factor Beta 1</g>

+EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis
+Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease
+Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis
+Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice
+Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-b1 mediated Smad2/3 and ERK1/2 activation
+Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a TGF-b1-dependent mechanism
+Methylation-mediated BMPER expression in fibroblast activation in vitro and lung fibrosis in mice in vivo
+Effects of doxycycline on production of growth factors and matrix metalloproteinases in pulmonary fibrosis
+MS80, a novel sulfated oligosaccharide, inhibits pulmonary fibrosis by targeting TGF-beta1 both in vitro and in vivo
+Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis
+Studies of hepatocyte growth factor in bronchoalveolar lavage fluid in chronic interstitial lung diseases
+Simvastatin attenuates TGF-b1-induced epithelial-mesenchymal transition in human alveolar epithelial cells
+Expression of 150-kDa oxygen-regulated protein (ORP150) stimulates bleomycin-induced pulmonary fibrosis and dysfunction in mice
+Kinase inhibitors fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue
+The small heat-shock protein aB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis
+CUX1/Wnt signaling regulates epithelial mesenchymal transition in EBV infected epithelial cells
+Idiopathic pulmonary fibrosis: an altered fibroblast proliferation linked to cancer biology
+Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function
+TGF-b1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner
+Focal adhesion kinase signaling determines the fate of lung epithelial cells in response to TGF-b
+The profibrotic cytokine transforming growth factor-b1 increases endothelial progenitor cell angiogenic properties
+Tannic acid attenuates TGF-b1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-b signaling in lung epithelial cells
+Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta
+Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis
+Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis
+Effects of thymosin b4 and its N-terminal fragment Ac-SDKP on TGF-b-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis
+The matricellular protein CCN1 enhances TGF-b1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury
+MicroRNA-326 regulates profibrotic functions of transforming growth factor-b in pulmonary fibrosis
+Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo
+An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices
+Differential effects of human neutrophil peptide-1 on growth factor and interleukin-8 production by human lung fibroblasts and epithelial cells
+Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice
+VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats
+Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression
+miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1
+Cysteine-rich protein 1 is regulated by transforming growth factor-b1 and expressed in lung fibrosis
+Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-b-induced senescence of human bronchial epithelial cells
+Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro
+Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis
+Epithelium-specific deletion of TGF-b receptor type II protects mice from bleomycin-induced pulmonary fibrosis
+Assessment of the effect of potential antifibrotic compounds on total and aVb6 integrin-mediated TGF-b activation
+Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis
+Genetic polymorphism in matrix metalloproteinase-9 and transforming growth factor-b1 and susceptibility to combined pulmonary fibrosis and emphysema in  a Chinese population
+Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-kB dependant TGF-b activation: a biphasic experimental study
+Effect of pirfenidone on proliferation, TGF-b-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
+Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis
+[Quantifying plasma levels of transforming growth factor beta1 in idiopathic pulmonary fibrosis]
+SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin
+TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)
+NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
+TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells
+MicroRNA-29c regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts
+Regulation of human lung fibroblast C1q-receptors by transforming growth factor-beta and tumor necrosis factor-alpha
+Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
+Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis
+Increased TGF-beta1 in the lungs of asbestos-exposed rats and mice: reduced expression in TNF-alpha receptor knockout mice
+Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms
+Pirfenidone inhibits TGF-b1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells
+BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis
+Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis
+Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis
+Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy
+Roles of p38 MAPK and JNK in TGF-b1-induced human alveolar epithelial to mesenchymal transition
+The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis
+Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells
+Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts
+Triptolide suppresses paraquat induced idiopathic pulmonary fibrosis by inhibiting TGFB1-dependent epithelial mesenchymal transition
+[The morphology and molecular bases of damage to the stem cell niche of respiratory acini in idiopathic interstitial pneumonias]
+PPAR-y ligands repress TGFb-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis
+WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts
+Melatonin attenuates TGFb1-induced epithelial-mesenchymal transition in lung alveolar epithelial cells
+MiR-5100 targets TOB2 to drive epithelial-mesenchymal transition associated with activating smad2/3 in lung epithelial cells
+Inhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-b-induced alveolar epithelial to mesenchymal transition
+Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts
+Absence of Thy-1 results in TGF-b induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts
+Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells
+Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis
+TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: tnf-alpha induces TGF-beta(1)
+Anchorage-independent colony growth of pulmonary fibroblasts derived from fibrotic human lung tissue
+Antifibrotic effects of cyclosporine A on TGF-b1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1a
+Forkhead Box F1 (FOXF1) represses cell growth, COL1 and ARPC2 expression in lung fibroblasts in vitro
+Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages
+Modulation of specific beta cell gene (re)expression during in vitro expansion of human pancreatic islet cells
+Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis
+Amplified canonical transforming growth factor-b signalling<i>via</i>heat shock protein 90 in pulmonary fibrosis
+Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis
+Activated human T lymphocytes inhibit TGFb-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2
+Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis
+Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy
+Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts
+N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro
+Transforming growth factor beta1 induces epithelial-to-mesenchymal transition of A549 cells
+X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis
+Idiopathic pulmonary fibrosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers
+Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases
+Effects of cigarette smoke extract on A549 cells and human lung fibroblasts treated with transforming growth factor-beta1 in a coculture system
+Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis
+Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-kB, Muc5ac, TNF-a and IL-1b
+Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts
+Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF
+RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis
+Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice
+Regulation of transforming growth factor-b1-driven lung fibrosis by galectin-3
+Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury

+[Pulmonary fibrosis--a therapeutic dilemma?]
+Overexpression of <d>squamous cell carcinoma</d> antigen in <d>idiopathic pulmonary fibrosis</d>: clinicopathological correlations
+Establishment of the mouse model of acute exacerbation of <d>idiopathic pulmonary fibrosis</d>
+Dehydroepiandrosterone has strong antifibrotic effects and is decreased in <d>idiopathic pulmonary fibrosis</d>
+<g>Plasminogen activator inhibitor 1</g>, fibroblast apoptosis resistance, and aging-related susceptibility to lung <d>fibrosis</d>
+Tumor <d>necrosis</d> factor superfamily 14 (<d>LIGHT</d>) controls <g>thymic stromal lymphopoietin</g> to drive <d>pulmonary fibrosis</d>
+<g>Pigment epithelium-derived factor</g> in <d>idiopathic pulmonary fibrosis</d>: a role in aberrant angiogenesis
+Peptide-mediated inhibition of <g>mitogen-activated protein kinase-activated protein kinase-2</g> ameliorates bleomycin-induced <d>pulmonary fibrosis</d>
+Role of integrin-<v>mediated </v><g>TGFbeta</g> <v>activation </v>in the pathogenesis of <d>pulmonary fibrosis</d>
+<g>Glucagon like peptide-1</g> attenuates bleomycin-induced <d>pulmonary fibrosis</d>, involving the <u>inactivation </u>of NF-kB in mice
+<g>miR-26a</g> suppresses EMT by disrupting the <g>Lin28B</g>/<g>let-7d</g> axis: potential cross-talks among miRNAs in <d>IPF</d>
+<g>Transgelin</g> is a direct target of <g>TGF-beta</g>/<g>Smad3</g>-dependent epithelial cell <d>migration in lung fibrosis</d>
+The mannose-6-phosphate analogue, PXS64, inhibits <d>fibrosis</d> via <g>TGF-b1</g> pathway in human lung fibroblasts
+<u>Reduced </u><e>expression </e>of <g>BMP3</g> contributes to the development of <d>pulmonary fibrosis</d> and predicts the unfavorable prognosis in IIP patients
+Role of <g>CD248</g> as a potential severity marker in <d>idiopathic pulmonary fibrosis</d>
+<g>BAX inhibitor-1</g>-associated <g>V-ATPase</g> glycosylation <v>enhances </v>collagen degradation in <d>pulmonary fibrosis</d>
+<g>Nuclear factor erythroid 2-related factor 2</g> nuclear translocation induces <d>myofibroblastic dedifferentiation</d> in <d>idiopathic pulmonary fibrosis</d>
+Cytokine gene polymorphisms and BALF cytokine levels in <d>interstitial lung diseases</d>
+<g>BARD1</g> mediates <g>TGF-b</g> signaling in <d>pulmonary fibrosis</d>
+Autophagy in <d>idiopathic pulmonary fibrosis</d>
+MS80, a novel sulfated oligosaccharide, inhibits <d>pulmonary fibrosis</d> by targeting <g>TGF-beta1</g> both in vitro and in vivo
+Protective role of gambogic acid in experimental <d>pulmonary fibrosis</d> in vitro and in vivo
+Sorafenib ameliorates bleomycin-induced <d>pulmonary fibrosis</d>: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation
+Expression of <g>suppressor of cytokine signaling 1</g> in the peripheral blood of patients with <d>idiopathic pulmonary fibrosis</d>
+Profibrotic role of <g>miR-154</g> in <d>pulmonary fibrosis</d>
+Anchorage-independent colony growth of pulmonary fibroblasts derived from fibrotic human lung tissue
+The latent form of <g>TGFbeta(1)</g> is induced by <g>TNFalpha</g> through an <g>ERK</g> specific pathway and is <v>activated </v>by asbestos-derived reactive oxygen species in vitro and in vivo
+Differential effects of human neutrophil peptide-1 on growth factor and <g>interleukin-8</g> production by human lung fibroblasts and epithelial cells
+Effects of particulate matter from straw burning on <d>lung fibrosis</d> in mice
+<g>miR  -221</g> targets <g>HMGA2</g> to inhibit bleomycin  -induced <d>pulmonary fibrosis</d> by regulating <g>TGF  -b1</g>/<g>Smad3</g>-induced EMT
+<g>EZH2</g> enhances the differentiation of fibroblasts into myofibroblasts in <d>idiopathic pulmonary fibrosis</d>
+Abrogation of <g>TGF-beta1</g>-induced fibroblast-myofibroblast differentiation by <g>histone deacetylase</g> <u>inhibition.</u> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a devastating disease with no known effective pharmacological therapy
+<g>AKT2</g>
+<g>TGF-b</g> activation and lung <d>fibrosis</d>
+<g>TIAM1</g> inhibits lung fibroblast differentiation in <d>pulmonary fibrosis</d>
+Targeting genes for treatment in <d>idiopathic pulmonary fibrosis</d>: challenges and opportunities, promises and pitfalls
+Epithelial Cell Mitochondrial Dysfunction and <g>PINK1</g>
+<l>Release </l>of biologically active <g>TGF-beta1</g> by alveolar epithelial cells results in <d>pulmonary fibrosis</d>
+Regulation of transforming growth factor-b1-driven lung <d>fibrosis</d> by <g>galectin-3</g>
+Epigenetic <r>Regulation </r>of <g>Caveolin-1</g>
+Role of endoplasmic reticulum stress in age-related susceptibility to lung <d>fibrosis</d>
+<d>Pulmonary fibrosis</d>: pathogenesis, etiology and regulation
+<g>PPAR</g>-y ligands repress <g>TGFb</g>-induced myofibroblast differentiation by targeting the <g>PI3K</g>/<g>Akt</g> pathway: implications for therapy of <d>fibrosis</d>
+De-ubiquitinating enzyme, <g>USP11</g>, promotes <g>transforming growth factor b-1</g> signaling through stabilization of transforming growth factor b receptor II
+<g>Neutrophil elastase</g> promotes myofibroblast <d>differentiation in lung fibrosis</d>
+<g>MAP3K19</g>
+Effect of Renshen Pingfei Decoction, a traditional Chinese prescription, on <d>IPF</d> <v>induced </v>by Bleomycin in rats and <r>regulation </r>of <g>TGF-b1</g>/<g>Smad3</g>
+Alveolar epithelial cells express mesenchymal proteins in patients with <d>idiopathic pulmonary fibrosis</d>
+Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion
+[The potential role of cytokines expression in <d>idiopathic pulmonary fibrosis</d>]
+Effect of an immunotoxin to <g>folate receptor beta</g> on bleomycin-induced <d>experimental pulmonary fibrosis</d>
+<v>Elevated </v><e>expression </e>of <g>NEU1</g> sialidase in <d>idiopathic pulmonary fibrosis</d> <v>provokes </v>pulmonary collagen deposition, <d>lymphocytosis</d>, and <d>fibrosis</d>
+N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition
+<g>CUX1</g>/Wnt signaling regulates epithelial mesenchymal transition in EBV infected epithelial cells
+Pirfenidone exerts antifibrotic effects through <u>inhibition </u>of GLI transcription factors
+<g>STAT3</g>-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF
+<g>N-acetyl-L-cysteine</g> inhibits <g>TGF-beta1</g>-induced profibrotic responses in fibroblasts
+Epithelium-specific deletion of <g>TGF-b</g> receptor type II protects mice from bleomycin-induced <d>pulmonary fibrosis</d>
+<g>Renin</g> is an angiotensin-independent profibrotic mediator: role in <d>pulmonary fibrosis</d>
+Beyond <g>TGFb</g> - Novel ways to target airway and parenchymal <d>fibrosis</d>
+<g>CXCL9</g>
+<g>MiR-5100</g> targets <g>TOB2</g> to drive epithelial-mesenchymal transition associated with <v>activating </v><g>smad2/3</g> in lung epithelial cells
+The impact of <g>TGF-b</g> on lung <d>fibrosis</d>: from targeting to biomarkers
+Mast cell chymase: an indispensable instrument in the pathological symphony of <d>idiopathic pulmonary fibrosis</d>? <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a chronic, progressive and fatal <d>lung disease</d> with no known etiology and treatment options
+Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-b Induced Myofibroblast Differentiation via Prostaglandin E2
+miR-18a-5p <u>Inhibits </u>Sub-pleural Pulmonary Fibrosis by Targeting <g>TGF-b</g>
+<g>Yin yang 1</g> is a novel regulator of <d>pulmonary fibrosis</d>
+<d>Idiopathic pulmonary fibrosis</d>: pathobiology of novel approaches to treatment
+MicroRNA regulatory networks in <d>idiopathic pulmonary fibrosis</d>
+Fibroblastic foci, covered with <d>alveolar epithelia</d> exhibiting <d>epithelial-mesenchymal transition</d>, destroy <d>alveolar septa</d> by disrupting blood flow in <d>idiopathic pulmonary fibrosis</d>
+<e>Overproduction </e>of collagen and <u>diminished </u><g>SOCS1</g> <e>expression </e>are causally linked in fibroblasts from <d>idiopathic pulmonary fibrosis</d>
+<d>Lung infection</d> with gamma-herpesvirus induces progressive <d>pulmonary fibrosis</d> in Th2-biased mice
+<g>Semaphorin 7a</g>+ regulatory T cells are associated with progressive <d>idiopathic pulmonary fibrosis</d> and are implicated in transforming growth factor-b1-induced <d>pulmonary fibrosis</d>
+Increased expression of 5-hydroxytryptamine2A/B receptors in <d>idiopathic pulmonary fibrosis</d>: a rationale for therapeutic intervention
+Latent cytomegalovirus infection exacerbates experimental <d>pulmonary fibrosis</d> by <v>activating </v><g>TGF-b1</g>
+<g>Microsomal prostaglandin E synthase-1</g> <u>deficiency </u>exacerbates <d>pulmonary fibrosis</d> induced by bleomycin in mice
+Accelerated epithelial cell senescence in <d>IPF</d> and the inhibitory role of <g>SIRT6</g> in <g>TGF-b</g>-induced senescence of human bronchial epithelial cells
+<g>Transforming growth factor-beta1</g> in <d>sarcoidosis</d>
+<g>TGF-b1</g> induces <g>tissue factor</g> expression in human lung fibroblasts in a <g>PI3K</g>/<g>JNK</g>/<g>Akt</g>-dependent and <g>AP-1</g>-dependent manner
+Immunomodulation by mesenchymal stem cells in treating human <d>autoimmune disease-associated lung fibrosis</d>
+Curcumin inhibits <d>fibrosis</d>-related effects in <d>IPF</d> fibroblasts and in mice following bleomycin-induced <d>lung injury</d>
+<g>NADPH oxidase-4</g> mediates myofibroblast activation and fibrogenic responses to <d>lung injury</d>
+Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of <d>lung inflammation</d> and <d>fibrosis</d>
+Roles of p38 MAPK and <g>JNK</g> in <g>TGF-b1</g>-induced human alveolar epithelial to mesenchymal transition
+Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with <d>idiopathic pulmonary fibrosis</d>
+<u>Inhibition </u>of <g>PI3K</g> prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I P110 isoforms
+<r>Effects </r>of doxycycline on <e>production </e>of growth factors and matrix metalloproteinases in <d>pulmonary fibrosis</d>
+Novel Mechanisms for the Antifibrotic Action of Nintedanib
+Pirfenidone inhibits myofibroblast differentiation and <d>lung fibrosis</d> development during insufficient mitophagy
+<g>VEGF</g> ameliorates pulmonary <d>hypertension</d> through inhibition of endothelial apoptosis in experimental lung <d>fibrosis</d> in rats
+<v>Increased </v><g>TGF-beta1</g> in the lungs of asbestos-exposed rats and mice: <u>reduced </u><e>expression </e>in <g>TNF-alpha</g> receptor knockout mice
+<r>Regulation </r>of <g>TGF-b</g> storage and activation in the human <d>idiopathic pulmonary fibrosis lung</d>
+<d>Microsatellite instability</d> in transforming growth factor-beta 1 type II receptor gene in alveolar lining epithelial cells of <d>idiopathic pulmonary fibrosis</d>
+miR-92a <r>regulates </r><g>TGF-b1</g>-<v>induced </v><g>WISP1</g> <e>expression </e>in <d>pulmonary fibrosis</d>
+Significant involvement of <g>CCL2</g> (<g>MCP-1</g>) in inflammatory disorders of the lung
+<g>TGF-beta</g>-induced EMT: mechanisms and implications for <d>fibrotic lung disease</d>
+The potential <r>role </r>of PDGF, <g>IGF-1</g>, <g>TGF-beta</g> <e>expression </e>in <d>idiopathic pulmonary fibrosis</d>
+<g>Connective tissue growth factor</g> <e>expression </e>and <v>induction </v>by <g>transforming growth factor-beta</g> is <u>abrogated </u>by simvastatin via a Rho signaling mechanism
+MOXIBUSTION HAS A POSITIVE EFFECT ON PULMONARY FIBROSIS: AN ALTERNATIVE APPROACH
+Molecular pathogenesis of <d>interstitial pneumonitis</d> with <g>TNF-alpha</g> transgenic mice
+The pathogenesis of <d>idiopathic pulmonary fibrosis</d>
+Participation of miR-200 in <d>pulmonary fibrosis</d>
+<g>Gremlin</g>-mediated decrease in bone morphogenetic protein signaling promotes <d>pulmonary fibrosis</d>
+Hyper-responsiveness of <d>IPF</d>/<d>UIP</d> fibroblasts: interplay between <g>TGFbeta1</g>, <g>IL-13</g> and <g>CCL2</g>

+Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast
+Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis
+y-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis
+Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells
+Anti-pulmonary fibrotic activity of salvianolic acid B was screened by a novel method based on the cyto-biophysical properties
+Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls
+Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis
+VCAM-1 is a TGF-b1 inducible gene upregulated in idiopathic pulmonary fibrosis
+Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis
+Combined inhibition of TGFb and PDGF signaling attenuates radiation-induced pulmonary fibrosis
+Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-kB in mice
+Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced pulmonary fibrosis
+Regulation of TGF-b storage and activation in the human idiopathic pulmonary fibrosis lung
+Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects
+Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF
+Association of HLA and cytokine gene polymorphisms with idiopathic pulmonary fibrosis
+Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis
+A translational preclinical model of interstitial pulmonary fibrosis and pulmonary hypertension: mechanistic pathways driving disease pathophysiology
+Pirfenidone for the treatment of idiopathic pulmonary fibrosis
+Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis
+Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-b signaling
+Blockade of the Wnt/b-catenin pathway attenuates bleomycin-induced pulmonary fibrosis
+Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis
+Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
+Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis
+Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis
+Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis
+Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention
+Signaling pathways and their miRNA regulators involved in the etiopathology of idiopathic pulmonary fibrosis (IPF) and hypersensitivity pneumonitis (HP)
+Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis
+Inhibitory effects of amines from Citrus reticulata on bleomycin-induced pulmonary fibrosis in rats
+Beyond TGFb - Novel ways to target airway and parenchymal fibrosis
+Elevated sL1-CAM levels in BALF and serum of IPF patients
+The potential application of strategic released apigenin from polymeric carrier in pulmonary fibrosis
+Epithelial contribution to the pro-fibrotic stiff microenvironment and myofibroblast population in lung fibrosis
+Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis
+Overproduction of collagen and diminished SOCS1 expression are causally linked in fibroblasts from idiopathic pulmonary fibrosis
+Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrophages in interstitial lung disease
+Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension
+Corilagin attenuates aerosol bleomycin-induced experimental lung injury
+Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease
+Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages
+Increased expression of protease nexin-1 in fibroblasts during idiopathic pulmonary fibrosis regulates thrombin activity and fibronectin expression
+Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)
+Microencapsulation of lefty-secreting engineered cells for pulmonary fibrosis therapy in mice
+p63 - Key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis
+Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis
+Molecular pathogenesis of interstitial pneumonitis with TNF-alpha transgenic mice
+Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions
+Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis
+Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis
+Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis
+Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis
+Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for idiopathic pulmonary fibrosis
+BAX inhibitor-1-associated V-ATPase glycosylation enhances collagen degradation in pulmonary fibrosis
+Idiopathic pulmonary fibrosis: pathobiology of novel approaches to treatment
+Novel pharmacological approaches to manage interstitial lung fibrosis in the twenty-first century
+IL-4 polymorphisms, HRCT score and lung tissue markers in idiopathic pulmonary fibrosis
+Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis
+[The expressions and meanings of BMP-7 and TGF-b in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia]
+Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of b1,3-glucuronosyltransferase I in pulmonary fibrosis
+Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression
+TGF-b1 T869C polymorphism may affect susceptibility to idiopathic pulmonary fibrosis and disease severity
+Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects
+Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis
+Comparison between conventional and "clinical" assessment of experimental lung fibrosis
+Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice
+Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis
+Transforming growth factor b1 (TGFb1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis
+Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in chronic fibrosing interstitial pneumonia
+Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
+Modulation of CD11c+ lung dendritic cells in respect to TGF-b in experimental pulmonary fibrosis
+Expression of suppressor of cytokine signaling 1 in the peripheral blood of patients with idiopathic pulmonary fibrosis
+Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts
+Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis
+Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
+Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis
+N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats
+Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases
+Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
+JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study
+Ambroxol hydrochloride in the management of idiopathic pulmonary fibrosis: Clinical trials are the need of the hour
+IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis
+TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease
+Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury
+Signalling pathways from NADPH oxidase-4 to idiopathic pulmonary fibrosis
+Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis
+Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations
+Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
+Microsomal prostaglandin E synthase-1 deficiency exacerbates pulmonary fibrosis induced by bleomycin in mice
+Preventive and therapeutic effects of thymosin b4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis
+Serpin B4 isoform overexpression is associated with aberrant epithelial proliferation and lung cancer in idiopathic pulmonary fibrosis
+Dehydroepiandrosterone has strong antifibrotic effects and is decreased in idiopathic pulmonary fibrosis
+Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis
+Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis
+Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis
+Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis
+High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations
+Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis
+Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice
+Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium
+Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis
+Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice
+Reduced expression of BMP3 contributes to the development of pulmonary fibrosis and predicts the unfavorable prognosis in IIP patients
+The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis
+The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosis
+An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model
+Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients
+Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis
+Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis
+Type V collagen induced tolerance suppresses collagen deposition, TGF-b and associated transcripts in pulmonary fibrosis
+Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia
+Effects of the tumor suppressor PTEN on the pathogenesis of idiopathic pulmonary fibrosis in Chinese patients
+The impact of TGF-b on lung fibrosis: from targeting to biomarkers
+Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosis
+Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis
+Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGFbeta1 expression
+Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis
+Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis
+Crosstalk between TGF-b1 and complement activation augments epithelial injury in pulmonary fibrosis
+Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis
+Current and novel drug therapies for idiopathic pulmonary fibrosis
+Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis
+Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis
+Data on CUX1 isoforms in idiopathic pulmonary fibrosis lung and systemic sclerosis skin tissue sections

+Assessment of the effect of potential antifibrotic compounds on total and aVb6 integrin-mediated TGF-b <v>activation.</v>
+Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in <d>idiopathic pulmonary fibrosis</d>
+<g>Syndecan-2</g> exerts antifibrotic effects by promoting <g>caveolin-1</g>-mediated transforming growth factor-b receptor I internalization and inhibiting transforming growth factor-b1 signaling
+Modulation of specific beta cell gene (re)expression during in vitro expansion of human pancreatic islet cells
+Amplification of <g>TGFb</g>
+[<d>Idiopathic pulmonary fibrosis</d> and <d>lung cancer</d>]
+<g>Periostin</g> promotes <d>fibrosis</d> and predicts progression in patients with <d>idiopathic pulmonary fibrosis</d>
+<g>CCN5</g> <v>overexpression </v>inhibits profibrotic phenotypes via the <g>PI3K</g>/Akt signaling pathway in lung fibroblasts isolated from patients with <d>idiopathic pulmonary fibrosis</d> and in an in vivo model of <d>lung fibrosis</d>
+<g>Extracellular superoxide dismutase</g> has a highly specific <l>localization </l>in <d>idiopathic pulmonary fibrosis</d>/<d>usual interstitial pneumonia</d>
+An ex vivo model to induce early <d>fibrosis</d>-like changes in human precision-cut lung slices
+The role of halofuginone in fibrosis: more to be explored? Fibrosis, which can be defined as an abnormal or excessive accumulation of extracellular matrix (ECM), particularly fibrillar collagens, is a key driver of progressive organ dysfunction in many inflammatory and metabolic diseases, including idiopathic pulmonary fibrosis (IPF), cirrhosis, nephropathy, and oral submucous fibrosis (OSF)
+Genomewide RNA expression profiling in lung identifies distinct signatures in <d>idiopathic pulmonary arterial hypertension</d> and <d>secondary pulmonary hypertension</d>
+Metformin <d>attenuates lung fibrosis</d> development via <g>NOX4</g> <u>suppression.</u>
+Cytokine gene polymorphisms and serum cytokine levels in patients with <d>idiopathic pulmonary fibrosis</d>
+Determining the True Selectivity Profile of av Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem
+Novel pharmacological approaches to manage <d>interstitial lung fibrosis</d> in the twenty-first century
+Lipoxin A4 Attenuates Constitutive and <g>TGF-b1</g>-Dependent Profibrotic Activity in Human Lung Myofibroblasts
+<g>Hsp90</g> <r>regulation </r>of fibroblast activation in <d>pulmonary fibrosis</d>
+<g>MiR-185</g>/<g>AKT</g> and <g>miR-29a</g>/collagen 1a pathways are <v>activated </v>in <d>IPF</d>
+<g>Wilms' tumor 1</g> (<g>Wt1</g>) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in <d>idiopathic pulmonary fibrosis</d>
+Kinase <u>inhibitors </u>fail to induce mesenchymal-epithelial transition in fibroblasts from fibrotic lung tissue
+Early growth response transcription factors: key mediators of <d>fibrosis</d> and novel targets for anti-fibrotic therapy
+<g>Toll-like receptor 4</g> activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with <d>IPF</d>
+Sphingosine-1-phosphate lyase is an endogenous suppressor of <d>pulmonary fibrosis</d>: role of <g>S1P</g> signalling and autophagy
+A translational preclinical model of <d>interstitial pulmonary fibrosis</d> and <d>pulmonary hypertension</d>: mechanistic pathways driving disease pathophysiology
+<g>PI3K</g> p110y <v>overexpression </v>in <d>idiopathic pulmonary fibrosis lung</d> tissue and fibroblast cells: in vitro effects of its inhibition
+Low-dose paclitaxel ameliorates <d>pulmonary fibrosis</d> by suppressing <g>TGF-b1</g>/<g>Smad3</g> pathway via <g>miR-140</g> upregulation
+MicroRNAs in <d>idiopathic pulmonary fibrosis</d>
+Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung <d>Fibrosis</d>
+Membrane type-matrix metalloproteinases in <d>idiopathic pulmonary fibrosis</d>
+Increased <d>alveolar</d> soluble <g>annexin V</g> promotes <d>lung inflammation</d> and <d>fibrosis</d>
+<g>TGF-b1</g> <v>induces </v><g>Fstl1</g> via the <g>Smad3</g>-<g>c-Jun</g> pathway in lung fibroblasts
+[Different cytokine profiles in <d>usual interstitial pneumonia</d> and <d>nonspecific interstitial pneumonia</d>]
+Simvastatin attenuates <g>TGF-b1</g>-induced epithelial-mesenchymal transition in human alveolar epithelial cells
+<g>Aortic carboxypeptidase-like protein</g> (<g>ACLP</g>) enhances lung myofibroblast differentiation through transforming growth factor b receptor-dependent and -independent pathways
+Tubastatin ameliorates <d>pulmonary fibrosis</d> by targeting the TGFb-PI3K-<g>Akt</g> pathway
+Lung fibrotic <g>tenascin-C</g> <v>upregulation </v>is associated with other extracellular matrix proteins and <v>induced </v>by TGFb1
+Tannic acid attenuates TGF-b1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-b signaling in lung epithelial cells
+Regulation of myofibroblast differentiation by <g>miR-424</g> during epithelial-to-mesenchymal transition
+MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation
+<g>Extracellular Matrix Metalloproteinase Inducer</g> (<g>EMMPRIN</g>) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts
+<v>Increased </v>interleukin-1 receptor antagonist in <d>idiopathic pulmonary fibrosis</d>
+Targeting <g>sphingosine kinase 1</g> attenuates bleomycin-induced <d>pulmonary fibrosis</d>
+Re-evaluation of fibrogenic cytokines in <d>lung fibrosis</d>
+Defect of pro-<g>hepatocyte growth factor</g> activation by fibroblasts in <d>idiopathic pulmonary fibrosis</d>
+IPF lung fibroblasts have a senescent phenotype
+Autophagy and <d>inflammation</d> in chronic <d>respiratory disease</d>
+The profibrotic cytokine <g>transforming growth factor-b1</g> increases endothelial progenitor cell angiogenic properties
+Expression of <g>150-kDa oxygen-regulated protein</g> (<g>ORP150</g>) stimulates bleomycin-induced <d>pulmonary fibrosis and dysfunction</d> in mice
+Activated MCTC mast cells infiltrate diseased lung areas in <d>cystic fibrosis</d> and <d>idiopathic pulmonary fibrosis</d>
+The antifibrotic effects and mechanisms of microRNA-26a action in <d>idiopathic pulmonary fibrosis</d>
+Phosphatase and tensin homolog deleted on chromosome 10 contributes to phenotype transformation of fibroblasts in <d>idiopathic pulmonary fibrosis</d> via multiple pathways
+Lower expression of platelet derived growth factor is associated with better overall survival rate of patients with idiopathic nonspecific interstitial pneumonia
+Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in <d>Idiopathic Pulmonary Fibrosis</d> (<d>IPF</d>)
+Macrophage <g>Bone Morphogenic Protein Receptor 2</g> (<g>BMPR2</g>) <u>depletion </u>in <d>Idiopathic Pulmonary Fibrosis</d> (<d>IPF</d>) and Group III Pulmonary <d>Hypertension</d>
+<g>Cartilage oligomeric matrix protein</g> in <d>idiopathic pulmonary fibrosis</d>
+Negative regulation of myofibroblast differentiation by <g>PTEN</g> (Phosphatase and Tensin Homolog Deleted on chromosome 10)
+<g>SPARC</g> suppresses apoptosis of <d>idiopathic pulmonary fibrosis</d> fibroblasts through constitutive <v>activation </v>of <g>beta-catenin</g>
+Lactic acid is elevated in <d>idiopathic pulmonary fibrosis</d> and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-b
+Epithelial cell alpha3beta1 integrin links <g>beta-catenin</g> and Smad signaling to promote myofibroblast formation and <d>pulmonary fibrosis</d>
+EMT and <d>interstitial lung disease</d>: a mysterious relationship
+Epithelial stem cell exhaustion in the pathogenesis of <d>idiopathic pulmonary fibrosis</d>
+Berberine attenuates bleomycin induced <d>pulmonary toxicity</d> and <d>fibrosis</d> via <u>suppressing </u><g>NF-kB</g> dependant <g>TGF-b</g> <v>activation:</v> a biphasic experimental study
+Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the <g>TGF-b1</g> <v>mediated </v><g>Smad2/3</g> and <g>ERK1/2</g> <v>activation.</v> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a chronic and usually progressive <d>lung disease</d> and the epithelial-mesenchymal transition (EMT) may play an important role in the pathogenesis of <d>pulmonary fibrosis</d>
+<g>TGF-beta1</g> induces human alveolar epithelial to mesenchymal cell transition (EMT)
+Thalidomide prevents bleomycin-induced <d>pulmonary fibrosis</d> in mice
+Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice
+Significance of <v>elevated </v>procollagen-III-peptide and <g>transforming growth factor-beta</g> levels of bronchoalveolar lavage fluids from <d>idiopathic pulmonary fibrosis</d> patients
+<g>MiR-338</g>* targeting <g>smoothened</g> to inhibit <d>pulmonary fibrosis</d> by epithelial-mesenchymal transition
+Proteasomal regulation of <d>pulmonary fibrosis</d>
+Role for alpha3 integrin in EMT and <d>pulmonary fibrosis</d>
+<g>Lysocardiolipin acyltransferase</g> regulates <g>TGF-b</g> mediated lung fibroblast differentiation
+Differing Expression of Cytokines and <d>Tumor</d>
+Carbon monoxide-bound hemoglobin-vesicles for the treatment of bleomycin-induced <d>pulmonary fibrosis</d>
+Tissue inhibitor of metalloproteinase-3 is up-regulated by <g>transforming growth factor-beta1</g> in vitro and expressed in fibroblastic foci in vivo in <d>idiopathic pulmonary fibrosis</d>
+Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with <d>Cryptogenic Organizing Pneumonia</d>
+Transforming growth factor-b <u>inhibits </u>IQ motif containing guanosine triphosphatase <v>activating </v>protein  1 <e>expression </e>in lung fibroblasts via the nuclear factor-kB signaling pathway
+Role of <d>von Hippel-Lindau</d> protein in fibroblast proliferation and <d>fibrosis</d>
+<g>X-linked inhibitor of apoptosis</g> regulates lung fibroblast resistance to Fas-mediated apoptosis
+Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts
+<r>Regulation </r>of 26S Proteasome Activity in <d>Pulmonary Fibrosis</d>
+Therapeutic targets in fibrotic pathways
+Mode of action of nintedanib in the treatment of <d>idiopathic pulmonary fibrosis</d>
+<v>Increased </v>deposition of chondroitin/dermatan sulfate glycosaminoglycan and <v>upregulation </v>of b1,3-glucuronosyltransferase I in <d>pulmonary fibrosis</d>
+Pathogenesis pathways of <d>idiopathic pulmonary fibrosis</d> in bleomycin-induced <d>lung injury</d> model in mice
+<r>Effects </r>of antifibrotic agents on <g>TGF-beta1</g>, <g>CTGF</g> and <g>IFN-gamma</g> <e>expression </e>in patients with <d>idiopathic pulmonary fibrosis</d>
+Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on <d>pulmonary fibrosis</d> in rat <d>idiopathic pulmonary fibrosis</d> models
+Epithelial-mesenchymal transition in chronic <d>hypersensitivity pneumonitis</d>
+Uncoupling of the profibrotic and hemostatic effects of <g>thrombin</g> in <d>lung fibrosis</d>
+Molecular targets in <d>pulmonary fibrosis</d>: the myofibroblast in focus
+<u>Reduced </u>transcription of the <g>Smad4</g> gene during <d>pulmonary carcinogenesis</d> in <d>idiopathic pulmonary fibrosis</d>
+Anti-fibrotic Role of aB-crystallin Inhibition in Pleural and Subpleural <d>Fibrosis</d>
+Reviews and prospectives of signaling pathway analysis in <d>idiopathic pulmonary fibrosis</d>
+Predisposition for disrepair in the aged lung
+N-acetylcysteine <u>downregulation </u>of <g>lysyl oxidase</g> activity alleviating bleomycin-induced <d>pulmonary fibrosis</d> in rats
+Evaluation of permeability alteration and epithelial-mesenchymal transition induced by <g>transforming growth factor-b1</g> in A549, NCI-H441, and Calu-3 cells: Development of an in vitro model of respiratory epithelial cells in <d>idiopathic pulmonary fibrosis</d>
+Epithelial contribution to the pro-fibrotic stiff microenvironment and myofibroblast population in lung <d>fibrosis</d>
+Interactions between <g>b-catenin</g> and <g>transforming growth factor-b</g> signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (<g>CREB)-binding protein</g> (<g>CBP</g>)
+<g>Syndecan-2</g> is a novel target of <g>insulin-like growth factor binding protein-3</g> and is <v>over-expressed </v>in <d>fibrosis</d>
+Membrane-anchored <g>Serine Protease</g> <g>Matriptase</g>
+The small heat-shock protein aB-crystallin is essential for the nuclear <l>localization </l>of <g>Smad4</g>: impact on <d>pulmonary fibrosis</d>
+Medical treatment for <d>pulmonary fibrosis</d>: current trends, concepts, and prospects
+Ambroxol hydrochloride in the management of <d>idiopathic pulmonary fibrosis</d>: Clinical trials are the need of the hour
+Combined <u>inhibition </u>of <g>TGFb</g> and PDGF signaling attenuates radiation-induced <d>pulmonary fibrosis</d>
+Diagnostic Values For Club Cell Secretory Protein (<g>CC16</g>) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema
+<e>Effects </e>of <g>thymosin b4</g> and its N-terminal fragment Ac-SDKP on <g>TGF-b</g>-treated human lung fibroblasts and in the mouse model of bleomycin-induced <d>lung fibrosis</d>
+An <u>inhibitor </u>of NADPH oxidase-4 attenuates established <d>pulmonary fibrosis</d> in a <d>rodent disease</d> model
+Human placental mesenchymal stem cells of fetal origins-alleviated <d>inflammation</d> and <d>fibrosis</d> by attenuating <g>MyD88</g> signaling in bleomycin-induced <d>pulmonary fibrosis</d> mice
+Roles for <g>insulin-like growth factor I</g> and <g>transforming growth factor-beta</g> in <d>fibrotic lung disease</d>
+Role of <g>caveolin-1</g> in <d>fibrotic diseases</d>
+Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of <d>pulmonary fibrosis</d>
+[The morphology and molecular bases of damage to the stem cell niche of respiratory acini in <d>idiopathic interstitial pneumonias</d>]
+Insulin-like growth factor binding proteins 3 and 5 are <v>overexpressed </v>in <d>idiopathic pulmonary fibrosis</d> and contribute to extracellular matrix deposition
+Rapamycin regulates connective tissue growth factor expression of lung epithelial cells via phosphoinositide 3-kinase
+Differential <e>expression </e>of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: <r>regulation </r>by alpha 4 beta 1-integrin crosslinking and <g>TGF-beta</g>
+Fibrotic myofibroblasts manifest genome-wide derangements of translational control
+The role of cytokines in human <d>lung fibrosis</d>
+Pirfenidone <u>inhibits </u><g>TGF-b1</g>-induced <e>over-expression </e>of collagen type I and <d>heat shock</d> protein 47 in A549 cells
+Sustained Activation of <g>Toll-Like Receptor 9</g>
+MiR-541-5p <r>regulates </r><d>lung fibrosis</d> by <r>targeting </r>cyclic nucleotide phosphodiesterase 1A
+<d>Autoimmunity</d> to Vimentin Is Associated with Outcomes of Patients with <d>Idiopathic Pulmonary Fibrosis</d>
+<g>TGF-beta 1</g>, but not <g>TGF-beta 2</g> or <g>TGF-beta 3</g>, is differentially present in epithelial cells of advanced <d>pulmonary fibrosis</d>: an immunohistochemical study
+<v>Increased </v><e>expression </e>of <g>protease nexin-1</g> in fibroblasts during <d>idiopathic pulmonary fibrosis</d> <r>regulates </r><g>thrombin</g> activity and <g>fibronectin</g> <e>expression.</e> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a chronic <d>diffuse lung disease</d> characterized by an accumulation of excess fibrous material in the lung
+<d>Idiopathic pulmonary fibrosis</d> in relation to gene polymorphisms of <g>transforming growth factor-b1</g> and <g>plasminogen activator inhibitor 1</g>
+<g>TNF-alpha</g>, PDGF, and <g>TGF-beta(1)</g> <e>expression </e>by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: <g>tnf-alpha</g> induces <g>TGF-beta(1)</g>

+Diagnostic Values For Club Cell Secretory Protein (CC16) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema
+Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts
+Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis
+Epithelial Cell Mitochondrial Dysfunction and PINK1 Are Induced by Transforming Growth Factor- Beta1 in Pulmonary Fibrosis
+The lncRNA H19 Mediates Pulmonary Fibrosis by Regulating the miR-196a/COL1A1 Axis
+Inhibition of PHGDH Attenuates Bleomycin-induced Pulmonary Fibrosis
+Transforming Growth Factor Beta 1 Activation, Storage, and Signaling Pathways in Idiopathic Pulmonary Fibrosis in Dogs
+Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with Idiopathic Pulmonary Fibrosis
+Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis
+Amplification of TGFb Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis
+Macrophage Bone Morphogenic Protein Receptor 2 (BMPR2) depletion in Idiopathic Pulmonary Fibrosis (IPF) and Group III Pulmonary Hypertension
+Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion
+Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
+Differing Expression of Cytokines and Tumor Markers in Combined Pulmonary Fibrosis and Emphysema Compared to Emphysema and Pulmonary Fibrosis
+miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-b Receptor II
+Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2
+Protective Effect of Ginsenoside Rg1 on Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of Caveolin-1 and TGF-b1 Signal Pathway
+Mesenchymal Stem Cells Correct Inappropriate Epithelial-mesenchyme Relation in Pulmonary Fibrosis Using Stanniocalcin-1
+Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production
+Transforming Growth Factor (TGF)-b Promotes de Novo Serine Synthesis for Collagen Production
+Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis
+Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-b Induced Myofibroblast Differentiation via Prostaglandin E2
+Inhibition of the KCa3.1 Channel Alleviates Established Pulmonary Fibrosis in a Large Animal Model
+AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation
+Novel Mechanisms for the Antifibrotic Action of Nintedanib
+Determining the True Selectivity Profile of av Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New Problem
+Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia
+Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin avb6 Expression
+Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis
+The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis
+MAP3K19 Is a Novel Regulator of TGF-b Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis
+Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-b1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt
+Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts: Possible Implications in Idiopathic Pulmonary Fibrosis
+Regulation of 26S Proteasome Activity in Pulmonary Fibrosis
+Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis
+The Role of PPARs in Lung Fibrosis
+Lipoxin A4 Attenuates Constitutive and TGF-b1-Dependent Profibrotic Activity in Human Lung Myofibroblasts
+Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells
+Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
+CXCL9 Regulates TGF-b1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells
+Anti-fibrotic Role of aB-crystallin Inhibition in Pleural and Subpleural Fibrosis
+Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-b and WNT7B in Human Lung Fibroblasts

+<r>Regulation </r>of human lung fibroblast <g>C1q</g>-receptors by <g>transforming growth factor-beta</g> and <g>tumor necrosis factor-alpha</g>
+High levels of <g>IL-6</g> and <g>IL-8</g> characterize early-on <d>idiopathic pulmonary fibrosis</d> acute exacerbations
+Regulation of the effects of <g>TGF-beta 1</g> by activation of latent <g>TGF-beta 1</g> and differential <e>expression </e>of <g>TGF-beta receptors (T beta R-I and T beta R-II</g>) in <d>idiopathic pulmonary fibrosis</d>
+Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in <d>idiopathic pulmonary fibrosis</d> patients
+<g>miR-9-5p</g> suppresses pro-fibrogenic transformation of fibroblasts and prevents organ <d>fibrosis</d> by targeting <g>NOX4</g> and <g>TGFBR2</g>
+Profibrotic role of <g>WNT10A</g> via <g>TGF-b</g> signaling in <d>idiopathic pulmonary fibrosis</d>
+Microarray profiling reveals <u>suppressed </u>interferon stimulated gene program in fibroblasts from scleroderma-associated <d>interstitial lung disease</d>
+<g>IL-4</g> polymorphisms, HRCT score and lung tissue markers in <d>idiopathic pulmonary fibrosis</d>
+Herpes <d>virus infection</d> is associated with vascular remodeling and <d>pulmonary hypertension</d> in <d>idiopathic pulmonary fibrosis</d>
+Microencapsulation of lefty-secreting engineered cells for <d>pulmonary fibrosis</d> therapy in mice
+Targeting of <g>Discoidin Domain Receptor 2</g> (<g>DDR2</g>) Prevents Myofibroblast Activation and Neovessel Formation During <d>Pulmonary Fibrosis</d>
+Role of <g>protease-activated receptor-2</g> in <d>idiopathic pulmonary fibrosis</d>
+<g>Chop</g>
+<g>VCAM-1</g> is a <g>TGF-b1</g> inducible gene <v>upregulated </v>in <d>idiopathic pulmonary fibrosis</d>
+<u>Suppression </u>of <g>plasminogen activator inhibitor-1</g> by RNA interference attenuates <d>pulmonary fibrosis</d>
+<g>JAK2</g> mediates <d>lung fibrosis</d>, <d>pulmonary vascular remodelling</d> and <d>hypertension</d> in <d>idiopathic pulmonary fibrosis</d>: an experimental study
+Melatonin attenuates <g>TGFb1</g>-induced epithelial-mesenchymal transition in lung alveolar epithelial cells
+<r>Deregulation </r>of selective autophagy during aging and <d>pulmonary fibrosis</d>: the role of <g>TGFb1</g>
+<g>RhoA</g> signaling <r>modulates </r><g>cyclin D1</g> <e>expression </e>in human lung fibroblasts; implications for <d>idiopathic pulmonary fibrosis</d>
+Inhibitory effect of <g>receptor for advanced glycation end products</g> (<g>RAGE</g>) on the <g>TGF-b</g>-induced alveolar epithelial to mesenchymal transition
+<e>Effects </e>of the <d>tumor</d> suppressor <g>PTEN</g> on the pathogenesis of <d>idiopathic pulmonary fibrosis</d> in Chinese patients
+Triptolide suppresses paraquat induced <d>idiopathic pulmonary fibrosis</d> by inhibiting <g>TGFB1</g>-dependent epithelial mesenchymal transition
+<g>Endothelin-1</g> <v>induces </v>alveolar epithelial-mesenchymal transition through endothelin type A receptor-<v>mediated </v><e>production </e>of <g>TGF-beta1</g>
+<g>p63</g> - Key molecule in the early phase of <d>epithelial abnormality</d> in <d>idiopathic pulmonary fibrosis</d>
+The hedgehog system machinery controls transforming growth factor-b-dependent myofibroblastic differentiation in humans: involvement in <d>idiopathic pulmonary fibrosis</d>
+<v>Upregulation </v>of <g>activin</g>-B and <g>follistatin</g> in <d>pulmonary fibrosis</d> - a translational study using human biopsies and a specific inhibitor in mouse <d>fibrosis</d> models
+<u>Inhibition </u>of the <g>KCa3.1</g>
+Current and novel drug therapies for <d>idiopathic pulmonary fibrosis</d>
+<g>Protease activated receptor-1</g> regulates macrophage-mediated cellular senescence: a risk for <d>idiopathic pulmonary fibrosis</d>
+Sphingolipids in <d>pulmonary fibrosis</d>
+Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts
+Pirfenidone for the treatment of <d>idiopathic pulmonary fibrosis</d>
+The anti-fibrotic effect of <u>inhibition </u>of <g>TGFb</g>-<g>ALK5</g> signalling in experimental <d>pulmonary fibrosis</d> in mice is attenuated in the presence of concurrent y-herpesvirus infection
+Angiotensin-<g>TGF-beta</g> 1 crosstalk in human <d>idiopathic pulmonary fibrosis</d>: autocrine mechanisms in myofibroblasts and macrophages
+SNAI transcription factors mediate epithelial-mesenchymal transition in <d>lung fibrosis</d>
+<g>MiR-338</g>* suppresses fibrotic pathogenesis in <d>pulmonary fibrosis</d> through targeting <g>LPA1</g>
+BALF N-acetylglucosaminidase and <g>beta-galactosidase</g> activities in <d>idiopathic pulmonary fibrosis</d>
+<g>Th1</g>/Th2 cytokine gene polymorphisms in patients with <d>idiopathic pulmonary fibrosis</d>
+Transforming Growth Factor (TGF)-b Promotes de Novo Serine Synthesis for Collagen <e>Production.</e> <g>TGF-b</g> <v>promotes </v>excessive collagen deposition in <d>fibrotic diseases</d> such as <d>idiopathic pulmonary fibrosis</d> (<d>IPF</d>)
+The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--b1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells
+<g>Transcription factor GATA-6</g> is <e>expressed </e>in quiescent myofibroblasts in <d>idiopathic pulmonary fibrosis</d>
+Epithelial-to-mesenchymal transition and its role in <g>EGFR</g>-mutant <d>lung adenocarcinoma</d> and <d>idiopathic pulmonary fibrosis</d>

+miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF
+MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells
+Tubastatin ameliorates pulmonary fibrosis by targeting the TGFb-PI3K-Akt pathway
+Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts
+Effects of particulate matter from straw burning on lung fibrosis in mice
+Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition
+Effect of substrate stiffness on pulmonary fibroblast activation by TGF-b
+Shikonin suppresses pulmonary fibroblasts proliferation and activation by regulating Akt and p38 MAPK signaling pathways
+Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis
+miR-92a regulates TGF-b1-induced WISP1 expression in pulmonary fibrosis
+Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis
+Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2
+Fibrotic myofibroblasts manifest genome-wide derangements of translational control
+Rapamycin increases CCN2 expression of lung fibroblasts via phosphoinositide 3-kinase
+Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis
+Latent cytomegalovirus infection exacerbates experimental pulmonary fibrosis by activating TGF-b1
+TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
+Lysocardiolipin acyltransferase regulates TGF-b mediated lung fibroblast differentiation
+Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis
+Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
+microRNA-1343 attenuates pathways of fibrosis by targeting the TGF-b receptors
+Effect of Renshen Pingfei Decoction, a traditional Chinese prescription, on IPF induced by Bleomycin in rats and regulation of TGF-b1/Smad3
+M2 macrophages induce EMT through the TGF-b/Smad2 signaling pathway
+miR  -221 targets HMGA2 to inhibit bleomycin  -induced pulmonary fibrosis by regulating TGF  -b1/Smad3-induced EMT
+FGF-1 reverts epithelial-mesenchymal transition induced by TGF-{beta}1 through MAPK/ERK kinase pathway
+Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation
+Human lung myofibroblast TGFb1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channels
+The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis
+MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation
+Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFb-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis
+Cub domain containing protein 1 (CDCP1) negatively regulates TGFb signaling and myofibroblast differentiation
+The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-b1 pathway in human lung fibroblasts
+Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2
+miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways
+Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-b1/Smad3 pathway via miR-140 upregulation
+MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition
+N-acetyl-L-cysteine inhibits TGF-beta1-induced profibrotic responses in fibroblasts
+Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways
+miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2
+Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis
+Leucine-rich a-2 glycoprotein promotes lung fibrosis by modulating TGF-b signaling in fibroblasts
+MiR-541-5p regulates lung fibrosis by targeting cyclic nucleotide phosphodiesterase 1A
+Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7
+STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF
+TGF-b1 induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts
+HSP27 regulates TGF-b mediated lung fibroblast differentiation through the Smad3 and ERK pathways
+SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis
+Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo
+Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1
+Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFb1
+Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition
+Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10)

+Comparison between conventional and "clinical" assessment of experimental lung <d>fibrosis</d>
+Developmental Reprogramming in Mesenchymal Stromal Cells of Human Subjects with <d>Idiopathic Pulmonary Fibrosis</d>
+<u>Inhibition </u>of <g>HSP27</g> blocks <d>fibrosis</d> development and EMT features by promoting <g>Snail</g> degradation
+<r>Effects </r>of a leukotriene B4 receptor antagonist on bleomycin-induced <d>pulmonary fibrosis</d>
+Activated human T lymphocytes inhibit <g>TGFb</g>-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2
+The potential application of strategic released apigenin from polymeric carrier in pulmonary fibrosis
+<g>Bone morphogenetic protein-4</g> inhibitor <g>gremlin</g> is <v>overexpressed </v>in <d>idiopathic pulmonary fibrosis</d>
+The K+ channel <g>KCa3.1</g> as a novel target for <d>idiopathic pulmonary fibrosis</d>
+<g>Spiruchostatin A</g> inhibits proliferation and differentiation of fibroblasts from patients with <d>pulmonary fibrosis</d>
+Lung myofibroblasts are characterized by <u>down-regulated </u><g>cyclooxygenase-2</g> and its main metabolite, prostaglandin E2
+Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells
+Effect of substrate stiffness on pulmonary fibroblast activation by <g>TGF-b</g>
+Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways
+Exercise <u>Reduces </u>Lung <d>Fibrosis</d>
+<e>Expression </e>of mucosa-related integrin alphaEbeta7 on <d>alveolar T</d> cells in <d>interstitial lung diseases</d>
+Fibroblasts from <d>idiopathic pulmonary fibrosis</d> and normal lungs differ in growth rate, apoptosis, and tissue <u>inhibitor </u>of metalloproteinases <e>expression.</e> <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a <d>chronic lung disorder</d> characterized by fibroblast proliferation and extracellular matrix accumulation
+<d>Idiopathic pulmonary fibrosis</d>: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers
+Amplified canonical transforming growth factor-b signalling<i>via</i><d>heat shock</d> protein 90 in <d>pulmonary fibrosis</d>
+Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced <d>pulmonary fibrosis progression</d>
+Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion
+Recent advances in molecular targets and treatment of <d>idiopathic pulmonary fibrosis</d>: focus on <g>TGFbeta</g> signaling and the myofibroblast
+<g>Bone morphogenetic protein</g>-inducer tilorone identified by high-throughput screening is antifibrotic in vivo
+Pleural mesothelial cell differentiation and invasion in <d>fibrogenic lung injury</d>
+Studies of <g>hepatocyte growth factor</g> in bronchoalveolar lavage fluid in chronic <d>interstitial lung diseases</d>
+Are mast cells instrumental for <d>fibrotic diseases</d>? <d>Idiopathic pulmonary fibrosis</d> (<d>IPF</d>) is a <d>fatal lung disorder</d> of unknown etiology characterized by accumulation of lung fibroblasts and extracellular matrix deposition, ultimately leading to compromised tissue architecture and lung function capacity
+Effects of <d>cigarette smoke extract</d> on A549 cells and human lung fibroblasts treated with <g>transforming growth factor-beta1</g> in a coculture system
+Differential mRNA expression of <g>insulin-like growth factor-1</g> splice variants in patients with <d>idiopathic pulmonary fibrosis</d> and <d>pulmonary sarcoidosis</d>
+<u>Reduced </u><g>Ets Domain-containing Protein Elk1</g>
+<g>HSP27</g> regulates <g>TGF-b</g> mediated lung fibroblast differentiation through the <g>Smad3</g> and <g>ERK</g> pathways
+<g>Transforming growth factor b1</g> (<g>TGFb1</g>)-induced CD44V6-<g>NOX4</g> signaling in pathogenesis of <d>idiopathic pulmonary fibrosis</d>
+Pleural mesothelial cells in <d>pleural and lung diseases</d>
+<d>Idiopathic pulmonary fibrosis</d>: an altered fibroblast proliferation linked to <d>cancer</d> biology
+Wnt coreceptor <g>Lrp5</g> is a driver of <d>idiopathic pulmonary fibrosis</d>
+The <g>JAK2</g> pathway is activated in <d>idiopathic pulmonary fibrosis</d>
+<g>miR-31</g> is a negative regulator of fibrogenesis and <d>pulmonary fibrosis</d>
+<g>NOX4</g>/NADPH oxidase <e>expression </e>is <v>increased </v>in pulmonary fibroblasts from patients with <d>idiopathic pulmonary fibrosis</d> and mediates <g>TGFbeta1</g>-induced fibroblast differentiation into myofibroblasts
+Matrix regulation of <d>idiopathic pulmonary fibrosis</d>: the role of enzymes
+[The expressions and meanings of <g>BMP-7</g> and <g>TGF-b</g> in <d>idiopathic pulmonary fibrosis</d> and <d>idiopathic nonspecific interstitial pneumonia</d>]
+Mesenchymal Stem Cells Correct Inappropriate Epithelial-mesenchyme Relation in <d>Pulmonary Fibrosis</d>
+Interstitial <d>fibrosis</d> and growth factors
+<u>Blockade </u>of the Wnt/b-catenin pathway attenuates bleomycin-induced <d>pulmonary fibrosis</d>
+Control of virus reactivation arrests pulmonary herpesvirus-induced <d>fibrosis</d> in IFN-gamma receptor-<u>deficient </u>mice
+Anti-pulmonary fibrotic activity of salvianolic acid B was screened by a novel method based on the cyto-biophysical properties
+Cytokines in human <d>lung fibrosis</d>
+<e>Expression </e>of <g>RXFP1</g>
+Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of <d>idiopathic pulmonary fibrosis</d>
+Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental <d>pulmonary fibrosis</d>
+y-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates <d>established murine lung fibrosis</d>
+Association of HLA and cytokine gene polymorphisms with <d>idiopathic pulmonary fibrosis</d>
+Signaling pathways and their miRNA regulators involved in the etiopathology of <d>idiopathic pulmonary fibrosis</d> (<d>IPF</d>) and <d>hypersensitivity pneumonitis</d> (<d>HP</d>)
+The role of microRNA-155/liver X receptor pathway in experimental and <d>idiopathic pulmonary fibrosis</d>
+<g>Cysteine-rich protein 1</g> is regulated by <g>transforming growth factor-b1</g> and expressed in lung <d>fibrosis</d>

+FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis
+Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent
+Hsp90 regulation of fibroblast activation in pulmonary fibrosis
+Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung
+BARD1 mediates TGF-b signaling in pulmonary fibrosis
+Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis
+Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis
+Mechanisms of fibrosis in coal workers' pneumoconiosis
+Role for alpha3 integrin in EMT and pulmonary fibrosis
+Molecular targets in pulmonary fibrosis: the myofibroblast in focus
+Increased alveolar soluble annexin V promotes lung inflammation and fibrosis
+Re-evaluation of fibrogenic cytokines in lung fibrosis
+A critical role for the mTORC2 pathway in lung fibrosis
+Inhibition and role of let-7d in idiopathic pulmonary fibrosis
+Predisposition for disrepair in the aged lung
+MicroRNA regulatory networks in idiopathic pulmonary fibrosis
+Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis
+Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy
+Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis
+[Idiopathic pulmonary fibrosis and lung cancer]
+Role of caveolin-1 in fibrotic diseases
+Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
+Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4
+[Potential role of cytokines in idiopathic pulmonary fibrosis]
+The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis
+Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10
+Therapeutic targets in fibrotic pathways
+Profibrotic role of WNT10A via TGF-b signaling in idiopathic pulmonary fibrosis
+Autophagy in idiopathic pulmonary fibrosis
+Overexpression of Sulf2 in idiopathic pulmonary fibrosis
+Matrix metalloproteinase (MMP)-19 deficient fibroblasts display a profibrotic phenotype
+[Pulmonary fibrosis--a therapeutic dilemma?]
+Signaling pathways in the epithelial origins of pulmonary fibrosis
+Participation of miR-200 in pulmonary fibrosis
+Proteasomal regulation of pulmonary fibrosis
+The JAK2 pathway is activated in idiopathic pulmonary fibrosis
+Transforming growth factor-beta1 in sarcoidosis
+Cytokines in human lung fibrosis
+Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis
+Cytokine gene polymorphisms in idiopathic pulmonary fibrosis
+Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis
+N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition
+Pulmonary fibrosis: pathogenesis, etiology and regulation
+Profibrotic role of miR-154 in pulmonary fibrosis
+IPF lung fibroblasts have a senescent phenotype
+Sphingolipids in pulmonary fibrosis
+Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis
+BALF N-acetylglucosaminidase and beta-galactosidase activities in idiopathic pulmonary fibrosis
+Transglutaminase 2 and its role in pulmonary fibrosis
+The role of cytokines in human lung fibrosis
+Pleural mesothelial cells in pleural and lung diseases
+[Different cytokine profiles in usual interstitial pneumonia and nonspecific interstitial pneumonia]
+Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis
+Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFb1
+MiR-338* suppresses fibrotic pathogenesis in pulmonary fibrosis through targeting LPA1
+Metformin attenuates lung fibrosis development via NOX4 suppression
+Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF)
+The pathogenesis of idiopathic pulmonary fibrosis
+Interstitial fibrosis and growth factors
+TIAM1 inhibits lung fibroblast differentiation in pulmonary fibrosis
+Role of von Hippel-Lindau protein in fibroblast proliferation and fibrosis
+miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
+miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis
+TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice
+Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes
+Epithelial-mesenchymal transition in chronic hypersensitivity pneumonitis
+Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
+[A role for mesothelial cells in the genesis of idiopathic pulmonary fibrosis?]
+Pathogenesis of idiopathic pulmonary fibrosis
+TGF-b activation and lung fibrosis
+Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice
+[The potential role of cytokines expression in idiopathic pulmonary fibrosis]
+Autophagy and inflammation in chronic respiratory disease
+Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis
+Membrane type-matrix metalloproteinases in idiopathic pulmonary fibrosis
+EMT and interstitial lung disease: a mysterious relationship
+Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
+Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
+MicroRNAs in idiopathic pulmonary fibrosis
+Yin yang 1 is a novel regulator of pulmonary fibrosis

+M2 macrophages <v>induce </v><g>EMT</g> through the <g>TGF-b</g>/<g>Smad2</g> signaling pathway
+Up-regulation of heparan sulfate 6-O-sulfation in <d>idiopathic pulmonary fibrosis</d>
+Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by <r>regulating </r><g>Nrf2</g>/<g>Bach1</g> equilibrium
+Signalling pathways from NADPH oxidase-4 to <d>idiopathic pulmonary fibrosis</d>
+The Role of PPARs in Lung <d>Fibrosis</d>
+Free radical generation induces epithelial-to-mesenchymal transition in lung epithelium via a <g>TGF-b1</g>-dependent mechanism
+<v>Overexpression </v>of <g>Sulf2</g> in <d>idiopathic pulmonary fibrosis</d>
+Essential role for the <g>ATG4B</g> protease and autophagy in bleomycin-induced <d>pulmonary fibrosis</d>
+Smooth muscle alpha-actin <e>expression </e>and myofibroblast differentiation by <g>TGFbeta</g> are <v>dependent </v>upon <g>MK2</g>
+<v>Elevated </v><g>sL1</g>-CAM levels in BALF and serum of <d>IPF</d> patients
+Microarray identifies ADAM family members as key responders to <g>TGF-beta1</g> in alveolar epithelial cells
+Titration of non-replicating adenovirus as a vector for <v>transducing </v>active <g>TGF-beta1</g> gene <e>expression </e>causing <d>inflammation</d> and fibrogenesis in the lungs of C57BL/6 mice
+A critical role for the <g>mTORC2</g> pathway in <d>lung fibrosis</d>
+<g>TGF-beta</g> driven lung <d>fibrosis</d> is macrophage dependent and blocked by Serum amyloid P
+Sputum biomarkers in <d>IPF</d>: Evidence for raised gene <e>expression </e>and protein level of <g>IGFBP-2</g>, <g>IL-8</g> and <g>MMP-7</g>
+<g>Forkhead Box F1</g> (<g>FOXF1</g>) <u>represses </u>cell growth, COL1 and <g>ARPC2</g> <e>expression </e>in lung fibroblasts in vitro
+<g>MicroRNA-29c</g> regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts
+<g>Prostaglandin F(2alpha) receptor</g> signaling facilitates bleomycin-induced <d>pulmonary fibrosis</d> independently of transforming growth factor-beta
+Cytoskeletal protein modulation in <d>pulmonary alveolar myofibroblasts</d> during <d>idiopathic pulmonary fibrosis</d>
+<g>Transglutaminase 2</g> and its role in <d>pulmonary fibrosis</d>
+Sunitinib, a Small-Molecule Kinase <u>Inhibitor,</u>
+<g>WISP1</g> mediates <g>IL-6</g>-dependent proliferation in primary human lung fibroblasts
+<v>Upregulation </v>of alveolar <e>levels </e>of activin B, but not activin A, in lungs of west highland white terriers with <d>idiopathic pulmonary fibrosis</d> and <d>diffuse alveolar damage</d>
+Absence of <g>Thy-1</g> results in <g>TGF-b</g> induced <g>MMP-9</g> expression and confers a profibrotic phenotype to human lung fibroblasts
+Shikonin suppresses pulmonary fibroblasts proliferation and activation by <r>regulating </r><g>Akt</g> and <g>p38</g>
+<g>TRPV4</g> mediates myofibroblast differentiation and <d>pulmonary fibrosis</d> in mice
+Modulation of <g>CD11c</g>+ lung dendritic cells in respect to <g>TGF-b</g> in experimental <d>pulmonary fibrosis</d>
+Induction of epithelial-mesenchymal transition in alveolar epithelial cells by <g>transforming growth factor-beta1</g>: potential role in <d>idiopathic pulmonary fibrosis</d>
+Cytokine gene polymorphisms in <d>idiopathic pulmonary fibrosis</d>
+<g>Cub domain containing protein 1</g> (<g>CDCP1</g>) negatively regulates TGFb signaling and myofibroblast differentiation
+Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in chronic fibrosing <d>interstitial pneumonia</d>
+Mechanisms of <d>fibrosis</d> in <d>coal workers' pneumoconiosis</d>
+Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts
+<g>miR</g>-323a-3p regulates <d>lung fibrosis</d> by targeting multiple profibrotic pathways
+<g>TGF-b1</g> <v>stimulates </v><g>HDAC4</g> nucleus-to-cytoplasm <l>translocation </l>and <g>NADPH oxidase 4</g>-derived reactive oxygen species in normal human lung fibroblasts
+MicroRNA-326 regulates profibrotic functions of transforming growth factor-b in <d>pulmonary fibrosis</d>
+Pathogenesis of <d>idiopathic pulmonary fibrosis</d>
+Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells
+<e>Expression </e>of <g>WNT5A</g> in <d>Idiopathic Pulmonary Fibrosis</d> and Its <r>Control </r>by <g>TGF-b</g> and <g>WNT7B</g> in Human Lung Fibroblasts
+<g>FGF-1</g> reverts epithelial-mesenchymal transition induced by <g>TGF-{beta}1</g> through MAPK/ERK kinase pathway
+Type II alveolar epithelial cells and interstitial fibroblasts express <g>connective tissue growth factor</g> in <d>IPF</d>
+<g>Caveolin-1</g>: a critical regulator of <d>lung fibrosis</d> in <d>idiopathic pulmonary fibrosis</d>
+<g>Cthrc1</g> lowers pulmonary collagen associated with bleomycin-induced <d>fibrosis</d> and protects lung function
+Protective Effect of Ginsenoside Rg1 on Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of <g>Caveolin-1</g> and <g>TGF-b1</g>
+<u>Defect </u>of <g>hepatocyte growth factor</g> <l>secretion </l>by fibroblasts in <d>idiopathic pulmonary fibrosis</d>
+Rapamycin <v>increases </v><g>CCN2</g> <e>expression </e>of lung fibroblasts via <g>phosphoinositide 3-kinase</g>
+Human lung myofibroblast <g>TGFb1</g>-dependent <g>Smad2/3</g> signalling is Ca(2+)-dependent and <r>regulated </r>by <g>KCa3.1</g>
+[A role for mesothelial cells in the genesis of <d>idiopathic pulmonary fibrosis</d>?]
+Antifibrotic effects of <g>cyclosporine A</g> on <g>TGF-b1</g>-treated lung fibroblasts and lungs from bleomycin-treated mice: role of <g>hypoxia-inducible factor-1a</g>
+<g>TGF-beta 1</g> as an enhancer of Fas-mediated apoptosis of lung epithelial cells
+Proliferation of pulmonary interstitial fibroblasts is mediated by <g>transforming growth factor-beta1</g>-induced release of extracellular <g>fibroblast growth factor-2</g> and <p>phosphorylation </p>of <g>p38</g>
+Prognostic factors for <d>idiopathic pulmonary fibrosis</d>: clinical, physiologic, pathologic, and molecular aspects
+Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts
+<g>Secreted protein acidic and rich in cysteine</g> (<g>SPARC</g>) is upregulated by transforming growth factor (TGF)-b and is required for <g>TGF-b</g>-induced hydrogen peroxide production in fibroblasts
+The lncRNA <g>H19</g>
+<e>Contribution </e>of the anaphylatoxin receptors, <g>C3aR</g> and <g>C5aR</g>, to the pathogenesis of <d>pulmonary fibrosis</d>
+Corilagin attenuates aerosol bleomycin-induced experimental <d>lung injury</d>
+[Potential role of cytokines in <d>idiopathic pulmonary fibrosis</d>]
+Protective role of andrographolide in bleomycin-induced <d>pulmonary fibrosis</d> in mice
+<g>Serpin B4</g> isoform overexpression is associated with aberrant epithelial proliferation and <d>lung cancer</d> in <d>idiopathic pulmonary fibrosis</d>
+Interplay between <g>RAGE</g>, <g>CD44</g>, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells
+Antifibrotic properties of receptor for advanced glycation end products in <d>idiopathic pulmonary fibrosis</d>
+Dysregulated Collagen Homeostasis by Matrix Stiffening and <g>TGF-b1</g> in Fibroblasts from <d>Idiopathic Pulmonary Fibrosis</d>
+TGF-b1 T869C polymorphism may affect susceptibility to <d>idiopathic pulmonary fibrosis</d> and disease severity
+Plasma <g>CCN2</g> (connective tissue growth factor; <g>CTGF</g>) is a potential biomarker in <d>idiopathic pulmonary fibrosis</d> (<d>IPF</d>)
+Azithromycin attenuates myofibroblast differentiation and lung <d>fibrosis</d> development through <d>proteasomal degradation</d> of <g>NOX4</g>
+Crosstalk between <g>TGF-b1</g> and complement activation augments epithelial <d>injury in pulmonary fibrosis</d>
+Bleomycin and <g>IL-1beta</g>-mediated <d>pulmonary fibrosis</d> is <g>IL-17A</g> dependent
+miR-199a-5p Is <v>upregulated </v>during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting <g>caveolin-1</g>
+Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during <d>idiopathic pulmonary fibrosis</d>
+<g>Transforming growth factor beta1</g> induces epithelial-to-mesenchymal transition of A549 cells
+The anti-fibrotic effects of microRNA-153 by <r>targeting </r><g>TGFBR-2</g> in <d>pulmonary fibrosis</d>
+<u>Defective </u>histone acetylation is <r>responsible </r>for the <u>diminished </u><e>expression </e>of <g>cyclooxygenase 2</g> in <d>idiopathic pulmonary fibrosis</d>
+Inhibition and role of <g>let-7d</g> in <d>idiopathic pulmonary fibrosis</d>
+Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to <g>TGF-beta1</g> in vitro
+<g>miR-21</g> mediates fibrogenic activation of pulmonary fibroblasts and lung <d>fibrosis</d>
+Inhibitory effects of amines from Citrus reticulata on bleomycin-induced <d>pulmonary fibrosis</d> in rats
+Thalidomide <u>reduces </u><g>IL-18</g>, <g>IL-8</g> and <g>TNF-alpha</g> <l>release </l>from alveolar macrophages in <d>interstitial lung disease</d>
+Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced <d>pulmonary fibrosis</d> in rats: Decisive role of <g>Bax</g>, <g>Nrf2</g>, <g>NF-kB</g>, <g>Muc5ac</g>, <g>TNF-a</g> and <g>IL-1b</g>
+The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in <d>Pulmonary Fibrosis</d>

@@ -7,4 +7,16 @@ Partition	Cluster	GeneDisease	Total
 4	1	17	48
 4	2	90	229
 4	3	25	42
-4	4	46	132
\ No newline at end of file
+4	4	46	132
+5	1	17	48
+5	2	49	104
+5	3	41	125
+5	4	25	42
+5	5	46	132
+6	1	17	48	
+6	2	49	104
+6	3	41	125	
+6	4	25	42
+6	5	15	52
+6	6	31	80
+